Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2023 | Oct. 31, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-38221 | |
Entity Registrant Name | Ecovyst Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 81-3406833 | |
Entity Address, Address Line One | 300 Lindenwood Drive | |
Entity Address, City or Town | Malvern | |
Entity Address, State or Province | PA | |
Entity Address, Postal Zip Code | 19355 | |
City Area Code | (484) | |
Local Phone Number | 617-1200 | |
Title of 12(b) Security | Common stock, par value $0.01 per share | |
Trading Symbol | ECVT | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 116,116,895 | |
Entity Central Index Key | 0001708035 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Sales | $ 173,326 | $ 232,533 | $ 518,310 | $ 637,419 |
Cost of goods sold | 120,142 | 164,864 | 367,662 | 462,156 |
Gross profit | 53,184 | 67,669 | 150,648 | 175,263 |
Selling, general and administrative expenses | 16,945 | 21,460 | 59,460 | 67,779 |
Other operating expense, net | 4,310 | 7,673 | 17,288 | 25,101 |
Operating income | 31,929 | 38,536 | 73,900 | 82,383 |
Equity in net (income) from affiliated companies | (4,708) | (3,169) | (16,305) | (17,422) |
Interest expense, net | 11,811 | 9,542 | 30,812 | 26,880 |
Other expense, net | 361 | 1,872 | 543 | 2,497 |
Income before income taxes | 24,465 | 30,291 | 58,850 | 70,428 |
Provision for income taxes | 7,891 | 8,966 | 17,625 | 21,983 |
Net income | $ 16,574 | $ 21,325 | $ 41,225 | $ 48,445 |
Net income per share: | ||||
Basic income per share (in dollars per share) | $ 0.14 | $ 0.16 | $ 0.35 | $ 0.36 |
Diluted income per share (in dollars per share) | $ 0.14 | $ 0.16 | $ 0.34 | $ 0.35 |
Weighted average shares outstanding: | ||||
Basic (in shares) | 116,446,085 | 132,622,105 | 119,042,161 | 136,115,598 |
Diluted (in shares) | 117,374,347 | 134,096,839 | 120,417,132 | 137,666,215 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 16,574 | $ 21,325 | $ 41,225 | $ 48,445 |
Other comprehensive income (loss), net of tax: | ||||
Pension and postretirement benefits | (213) | (962) | 228 | (1,040) |
Net gain (loss) from hedging activities | 1,128 | 9,141 | (1,393) | 27,620 |
Foreign currency translation | (3,112) | (7,207) | (99) | (17,506) |
Total other comprehensive income (loss) | (2,197) | 972 | (1,264) | 9,074 |
Comprehensive income | $ 14,377 | $ 22,297 | $ 39,961 | $ 57,519 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash and cash equivalents | $ 38,317 | $ 110,920 |
Accounts receivable, net | 83,793 | 74,758 |
Inventories, net | 48,263 | 44,362 |
Derivative assets | 16,374 | 18,510 |
Prepaid and other current assets | 17,570 | 19,154 |
Total current assets | 204,317 | 267,704 |
Investments in affiliated companies | 441,769 | 436,013 |
Property, plant and equipment, net | 580,809 | 584,889 |
Goodwill | 403,368 | 403,163 |
Other intangible assets, net | 119,522 | 129,932 |
Right-of-use lease assets | 26,431 | 28,265 |
Other long-term assets | 36,609 | 34,587 |
Total assets | 1,812,825 | 1,884,553 |
LIABILITIES | ||
Current maturities of long-term debt | 9,000 | 9,000 |
Accounts payable | 32,308 | 40,019 |
Operating lease liabilities—current | 8,503 | 8,155 |
Accrued liabilities | 50,611 | 72,229 |
Total current liabilities | 100,422 | 129,403 |
Long-term debt, excluding current portion | 860,668 | 865,870 |
Deferred income taxes | 134,828 | 136,184 |
Operating lease liabilities—noncurrent | 17,871 | 20,021 |
Other long-term liabilities | 21,180 | 25,846 |
Total liabilities | 1,134,969 | 1,177,324 |
Commitments and contingencies (Note 15) | ||
EQUITY | ||
Common stock ($0.01 par); authorized shares 450,000,000; issued shares 140,744,045 and 139,571,272 on September 30, 2023 and December 31, 2022, respectively; outstanding shares 116,116,895 and 122,186,238 on September 30, 2023 and December 31, 2022, respectively | 1,407 | 1,396 |
Preferred stock ($0.01 par); authorized shares 50,000,000; no shares issued or outstanding on September 30, 2023 and December 31, 2022 | 0 | 0 |
Additional paid-in capital | 1,099,216 | 1,091,475 |
Accumulated deficit | (200,785) | (242,010) |
Treasury stock, at cost; shares 24,627,150 and 17,385,034 on September 30, 2023 and December 31, 2022, respectively | (226,710) | (149,624) |
Accumulated other comprehensive income | 4,728 | 5,992 |
Total equity | 677,856 | 707,229 |
Total liabilities and equity | $ 1,812,825 | $ 1,884,553 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common stock, par (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized shares (in shares) | 450,000,000 | 450,000,000 |
Common stock, issued shares (in shares) | 140,744,045 | 139,571,272 |
Common stock, outstanding shares (in shares) | 116,116,895 | 122,186,238 |
Preferred stock, par (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized shares (in shares) | 50,000,000 | 50,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Treasury stock (in shares) | 24,627,150 | 17,385,034 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common stock | Additional paid-in capital | (Accumulated deficit) | Treasury stock, at cost | Accumulated other comprehensive income (loss) |
Beginning balance at Dec. 31, 2021 | $ 740,737 | $ 1,378 | $ 1,073,409 | $ (315,707) | $ (12,551) | $ (5,792) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 7,875 | 7,875 | ||||
Total other comprehensive income (loss) | 11,378 | 11,378 | ||||
Tax withholdings on equity award vesting | (332) | (332) | ||||
Stock compensation expense | 5,946 | 5,946 | ||||
Shares issued under equity incentive plan, net of forfeitures | 27 | 18 | 9 | |||
Ending balance at Mar. 31, 2022 | 765,631 | 1,396 | 1,079,364 | (307,832) | (12,883) | 5,586 |
Beginning balance at Dec. 31, 2021 | 740,737 | 1,378 | 1,073,409 | (315,707) | (12,551) | (5,792) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 48,445 | |||||
Total other comprehensive income (loss) | 9,074 | |||||
Tax withholdings on equity award vesting | (332) | |||||
Ending balance at Sep. 30, 2022 | 739,525 | 1,395 | 1,088,704 | (267,262) | (86,594) | 3,282 |
Beginning balance at Mar. 31, 2022 | 765,631 | 1,396 | 1,079,364 | (307,832) | (12,883) | 5,586 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 19,245 | 19,245 | ||||
Total other comprehensive income (loss) | (3,276) | (3,276) | ||||
Repurchases of common shares | (8,842) | (8,842) | ||||
Stock compensation expense | 5,409 | 5,409 | ||||
Shares issued under equity incentive plan, net of forfeitures | 17 | 17 | ||||
Ending balance at Jun. 30, 2022 | 778,184 | 1,396 | 1,084,790 | (288,587) | (21,725) | 2,310 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 21,325 | 21,325 | ||||
Total other comprehensive income (loss) | 972 | 972 | ||||
Repurchases of common shares | (64,869) | (64,869) | ||||
Stock compensation expense | 3,872 | 3,872 | ||||
Shares issued under equity incentive plan, net of forfeitures | 41 | (1) | 42 | |||
Ending balance at Sep. 30, 2022 | 739,525 | 1,395 | 1,088,704 | (267,262) | (86,594) | 3,282 |
Beginning balance at Dec. 31, 2022 | 707,229 | 1,396 | 1,091,475 | (242,010) | (149,624) | 5,992 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | (1,471) | (1,471) | ||||
Total other comprehensive income (loss) | (5,759) | (5,759) | ||||
Repurchases of common shares | (29,850) | (29,850) | ||||
Tax withholdings on equity award vesting | (866) | (866) | ||||
Stock compensation expense | 4,756 | 4,756 | ||||
Shares issued under equity incentive plan, net of forfeitures | 112 | 10 | 102 | |||
Ending balance at Mar. 31, 2023 | 674,151 | 1,406 | 1,096,333 | (243,481) | (180,340) | 233 |
Beginning balance at Dec. 31, 2022 | 707,229 | 1,396 | 1,091,475 | (242,010) | (149,624) | 5,992 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 41,225 | |||||
Total other comprehensive income (loss) | (1,264) | |||||
Tax withholdings on equity award vesting | (3,372) | |||||
Ending balance at Sep. 30, 2023 | 677,856 | 1,407 | 1,099,216 | (200,785) | (226,710) | 4,728 |
Beginning balance at Mar. 31, 2023 | 674,151 | 1,406 | 1,096,333 | (243,481) | (180,340) | 233 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 26,122 | 26,122 | ||||
Total other comprehensive income (loss) | 6,692 | 6,692 | ||||
Repurchases of common shares | (43,524) | (43,524) | ||||
Excise tax on repurchases of common shares | (630) | (630) | ||||
Stock compensation expense | 4,739 | 4,739 | ||||
Shares issued under equity incentive plan, net of forfeitures | 214 | 1 | 213 | |||
Ending balance at Jun. 30, 2023 | 667,764 | 1,407 | 1,101,285 | (217,359) | (224,494) | 6,925 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income (loss) | 16,574 | 16,574 | ||||
Total other comprehensive income (loss) | (2,197) | (2,197) | ||||
Repurchases of common shares | (5,344) | (5,344) | ||||
Tax withholdings on equity award vesting | (2,506) | (2,506) | ||||
Excise tax on repurchases of common shares | (8) | (8) | ||||
Stock compensation expense | 3,392 | 3,392 | ||||
Shares issued under equity incentive plan, net of forfeitures | 181 | (5,461) | 5,642 | |||
Ending balance at Sep. 30, 2023 | $ 677,856 | $ 1,407 | $ 1,099,216 | $ (200,785) | $ (226,710) | $ 4,728 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 41,225 | $ 48,445 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 51,920 | 48,256 |
Amortization | 10,536 | 10,547 |
Amortization of deferred financing costs and original issue discount | 1,548 | 1,515 |
Foreign currency exchange (gain) loss | (41) | 2,179 |
Deferred income tax provision | (1,011) | 12,454 |
Net loss on asset disposals | 3,326 | 1,174 |
Stock compensation | 12,547 | 17,419 |
Equity in net income from affiliated companies | (16,305) | (17,422) |
Dividends received from affiliated companies | 10,000 | 30,000 |
Other, net | (5,270) | (2,603) |
Working capital changes that provided (used) cash: | ||
Receivables | (8,939) | (28,443) |
Inventories | (3,909) | 3,206 |
Prepaids and other current assets | 856 | (5,223) |
Accounts payable | (3,694) | 1,954 |
Accrued liabilities | (19,383) | (14,133) |
Net cash provided by operating activities | 73,406 | 109,325 |
Cash flows from investing activities: | ||
Purchases of property, plant and equipment | (53,642) | (39,474) |
Payments for business divestiture, net of cash | 0 | (3,744) |
Business combinations, net of cash acquired | 0 | (488) |
Other, net | 0 | 81 |
Net cash used in investing activities | (53,642) | (43,625) |
Cash flows from financing activities: | ||
Draw down of revolving credit facilities | 14,500 | 0 |
Repayments of revolving credit facilities | (14,500) | 0 |
Repayments of long-term debt | (6,750) | (6,750) |
Repurchases of common shares | (78,717) | (73,711) |
Tax withholdings on equity award vesting | (3,372) | (332) |
Repayment of financing obligation | (2,087) | (1,849) |
Other, net | 457 | 84 |
Net cash used in financing activities | (90,469) | (82,558) |
Effect of exchange rate changes on cash and cash equivalents | (1,898) | (2,585) |
Net change in cash and cash equivalents | (72,603) | (19,443) |
Cash and cash equivalents at beginning of period | 110,920 | 140,889 |
Cash and cash equivalents at end of period | $ 38,317 | $ 121,446 |
Background and Basis of Present
Background and Basis of Presentation | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Background and Basis of Presentation | 1. Background and Basis of Presentation: Description of Business Ecovyst Inc. and subsidiaries (the “Company” or “Ecovyst”) is a leading integrated and innovative global provider of specialty catalysts and services. The Company supports customers globally through its strategically located network of manufacturing facilities. The Company believes that its products, which are predominantly inorganic, and services contribute to improving the sustainability of the environment. The Company has two uniquely positioned specialty businesses: Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining and industrial applications; and Catalyst Technologies provides finished silica catalysts and catalyst supports necessary to produce high strength and high stiffness plastics and, through the Zeolyst Joint Venture, supplies zeolites used for catalysts that help produce renewable fuels, remove nitrogen oxides from diesel engine emissions as well as sulfur from fuels during the refining process. The Company’s regeneration services product group, which is a part of the Company’s Ecoservices segment, typically experiences seasonal fluctuations as a result of higher demand for gasoline products in the summer months and lower demand in the winter months. These demand fluctuations result in higher sales and working capital requirements in the second and third quarters. Basis of Presentation The condensed consolidated financial statements included herein are unaudited. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations for interim reporting. In the opinion of management, all adjustments of a normal and recurring nature necessary to state fairly the financial position and results of operations have been included. The results of operations are not necessarily indicative of the expected results for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Correction of an Error During the preparation of the condensed consolidated financial statements for the period ended June 30, 2023, the Company identified a presentation error in the components of accumulated other comprehensive income (loss) that originated in the year ended December 31, 2021 and remained uncorrected through the quarter ended March 31, 2023. As a result, the presentation of accumulated other comprehensive income (loss) in Note 5 was corrected by revising the opening balances as follows: Defined benefit and other postretirement plans Net gain (loss) from hedging activities Foreign currency translation As reported, December 31, 2021 $ 14,808 $ 2,254 $ (22,854) Correction to opening balances (12,640) (1,964) 14,604 Revised, December 31, 2021 $ 2,168 $ 290 $ (8,250) As reported, December 31, 2022 $ 12,132 $ 26,636 $ (32,776) Correction to opening balances (12,640) (1,964) 14,604 Revised, December 31, 2022 $ (508) $ 24,672 $ (18,172) This classification error within accumulated other comprehensive income (loss) did not impact total accumulated other comprehensive income (loss) for the periods included in these condensed consolidated financial statements. Additionally, there was no impact on the condensed consolidated statements of income and other comprehensive income (loss), condensed consolidated balance sheets and condensed consolidated statements of cash flows for the periods included in these condensed consolidated financial statements. The Company assessed the materiality of this presentation error and concluded it was not material to the Company’s previously issued financial statements. |
New Accounting Standards
New Accounting Standards | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
New Accounting Standards | 2. New Accounting Standards: Recently Adopted Accounting Standards In October 2023, the Financial Accounting Standards Board (“FASB”) issued guidance to amend either presentation or disclosure requirements related to fourteen subtopics in the FASB Accounting Standards Codification, that are currently in the SEC Regulation S-X or Regulation S-K. The new guidance was issued in response to the SEC’s ruling on disclosure simplification. For entities subject to existing SEC disclosure requirements, the effective date of each amendment of the topics will be the date that the SEC removes the related disclosure from Regulation S-X or Regulation S-K. The guidance must be applied prospectively, with no early adoption permitted for entities subject to those existing SEC disclosures. The Company is currently evaluating the impact of the new guidance as it pertains to the fourteen subtopics that would impact the business and will apply prospectively once in effect. In August 2023, the FASB issued guidance for entities that meet the definition of a joint venture or a corporate joint venture, to adopt a new basis of accounting upon the formation of the joint venture. The new guidance requires the initial measurement of contributed net assets and liabilities at fair value on the formation date, recognition of goodwill for the difference between the fair value of the joint venture’s equity and net assets, and disclosures about the nature and financial impact of the transaction. The new guidance requires prospective application and is effective for all joint ventures that are formed on or after January 1, 2025, with early adoption permitted. Joint ventures that formed before January 1, 2025 may elect to retrospectively apply the new guidance. The Company will apply the guidance to any new joint ventures formed after the effective date. In March 2020 and January 2021, the FASB issued guidance to address certain accounting consequences from the anticipated transition from the use of the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. The new guidance contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance is optional and may be elected over time as reference rate reform activities occur. The time period through which the practical expedients provided in the guidance is available was set to expire on December 31, 2022, but was extended through December 31, 2024 by the FASB in December 2022. During the year ended December 31, 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index of the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. In February 2023, the Company amended the 2021 Term Loan Facility (as defined below), the ABL Facility (as defined below) and all existing interest rate caps agreements to replace LIBOR with a secured overnight financing rate (“SOFR”) as the benchmark interest rate. See Note 11 and Note 12 to these condensed consolidated financial statements for additional information. The Company utilized the practical expedients under the guidance with respect to the transition of its debt facilities and interest rate hedging arrangements to SOFR, with no impact to its condensed consolidated financial statements. In October 2021, the FASB issued guidance that requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with revenue recognition guidance. Under current GAAP, contract assets and contract liabilities acquired in a business combination are recorded by the acquirer at fair value. The new guidance creates an exception to the general recognition and measurement principles related to business combinations, and is expected to result in the acquirer recognizing contract assets and liabilities at the same amounts recorded by the acquiree. The new guidance is effective for business combinations occurring during fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. The Company adopted the new guidance effective January 1, 2023 as required, and will apply the guidance prospectively to business combinations that occur after the adoption date. |
Revenue from Contracts with Cus
Revenue from Contracts with Customers | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenue from Contracts with Customers | 3. Revenue from Contracts with Customers: Disaggregated Revenue The Company’s primary means of disaggregating revenues is by reportable segments, which can be found in Note 16 to these condensed consolidated financial statements. The Company’s portfolio of products is integrated into a variety of end uses, which are described in the table below. Key End Uses Key Products Clean fuels, emission control & other • Refining hydrocracking catalysts • Emission control catalysts • Catalysts used in production of renewable fuels • Catalyst activation • Aluminum sulfate solution • Ammonium bisulfite solution Polymers & engineered plastics • Catalysts for high-density polyethylene and chemicals syntheses • Antiblocks for film packaging • Niche custom catalyst Regeneration and treatment services • Sulfuric acid regeneration services • Treatment services Industrial, mining & automotive • Sulfur derivatives for industrial production • Sulfuric acid for mining • Sulfuric derivatives for nylon production The following tables disaggregate the Company’s sales, by segment and end uses, for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 8,393 $ — $ 8,393 Polymers & engineered plastics — 25,697 25,697 Regeneration and treatment services (1) 87,692 — 87,692 Industrial, mining & automotive 51,544 — 51,544 Total segment sales $ 147,629 $ 25,697 $ 173,326 Three months ended September 30, 2022 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 7,991 $ — $ 7,991 Polymers & engineered plastics — 36,859 36,859 Regeneration and treatment services (1) 92,676 — 92,676 Industrial, mining & automotive 95,007 — 95,007 Total segment sales $ 195,674 $ 36,859 $ 232,533 Nine months ended September 30, 2023 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 21,559 $ — $ 21,559 Polymers & engineered plastics — 74,877 74,877 Regeneration and treatment services (1) 274,529 — 274,529 Industrial, mining & automotive 147,345 — 147,345 Total segment sales $ 443,433 $ 74,877 $ 518,310 Nine months ended September 30, 2022 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 22,474 $ — $ 22,474 Polymers & engineered plastics — 94,716 94,716 Regeneration and treatment services (1) 253,793 — 253,793 Industrial, mining & automotive 266,436 — 266,436 Total segment sales $ 542,703 $ 94,716 $ 637,419 (1) As described in Note 1 to these condensed consolidated financial statements, the Company experiences seasonal s ales fluctuations to customers in the regeneration services product group. (2) Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 9 to these condensed consolidated financial statements for further information). |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | 4. Fair Value Measurements: Fair values are based on quoted market prices when available. When market prices are not available, fair values are generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality. In instances where there is little or no market activity for the same or similar instruments, the Company estimates fair values using methods, models and assumptions that management believes a hypothetical market participant would use to determine a current transaction price. These valuation techniques involve some level of management estimation and judgment that becomes significant with increasingly complex instruments or pricing models. Where appropriate, adjustments are included to reflect the risk inherent in a particular methodology, model or input used. The Company’s financial assets and liabilities carried at fair value have been classified based upon a fair value hierarchy. The hierarchy gives the highest ranking to fair values determined using unadjusted quoted prices in active markets for identical assets and liabilities (Level 1) and the lowest ranking to fair values determined using methodologies and models with unobservable inputs (Level 3). The classification of an asset or a liability is based on the lowest level input that is significant to its measurement. For example, a Level 3 fair value measurement may include inputs that are both observable (Levels 1 and 2) and unobservable (Level 3). The levels of the fair value hierarchy are as follows: • Level 1—Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Active markets provide pricing data for trades occurring at least weekly and include exchanges and dealer markets. • Level 2—Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads and yield curves. • Level 3—Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date. The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. September 30, Quoted Prices in Significant Other Significant Derivative assets: Interest rate caps (Note 12) $ 32,178 $ — $ 32,178 $ — December 31, Quoted Prices in Significant Other Significant Derivative assets: Interest rate caps (Note 12) $ 34,374 $ — $ 34,374 $ — Derivative liabilities: Interest rate caps (Note 12) $ 2,071 $ — $ 2,071 $ — Derivative contracts Derivative assets and liabilities can be exchange-traded or traded over-the-counter (“OTC”). The Company generally values exchange-traded derivatives using models that calibrate to market transactions and eliminate timing differences between the closing price of the exchange-traded derivatives and their underlying instruments. OTC derivatives are valued using market transactions and other market evidence whenever possible, including market-based inputs to models, model calibration to market transactions, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. When models are used, the selection of a particular model to value an OTC derivative depends on the contractual terms of, and specific risks inherent in, the instrument as well as the availability of pricing information in the market. The Company generally uses similar models to value similar instruments. Valuation models require a variety of inputs, including contractual terms, market prices and rates, forward curves, measures of volatility, and correlations of such inputs. For OTC derivatives that trade in liquid markets, such as forward contracts, swaps and options, model inputs can generally be corroborated by observable market data by correlation or other means, and model selection does not involve significant management judgment. As of September 30, 2023, th e Company had interest rate c aps th at were fair valued using Level 2 inputs. In addition, the Company applies a credit valuation adjustment to reflect credit risk which is calculated based on credit default swaps. To the extent that the Company’s net exposure under a specific master agreement is an asset, the Company utilizes the counterparty’s default swap rate. If the net exposure under a specific master agreement is a liability, the Company utilizes a default swap rate comparable to Ecovyst. The credit valuation adjustment is added to the discounted fair value to reflect the exit price that a market participant would be willing to receive to assume the Company’s liabilities or that a market participant would be willing to pay for the Company’s assets. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Stockholders' Equity | 5. Stockholders' Equity: Accumulated Other Comprehensive Income (Loss) The following tables present the tax effects of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 2022 Pre-tax Tax benefit/ After-tax amount Pre-tax Tax benefit/ After-tax amount Defined benefit and other postretirement plans: Net prior service credit (cost) $ (31) $ 8 $ (23) $ (53) $ 13 $ (40) Net gain (loss) (253) 63 (190) (1,226) 304 (922) Benefit plans, net (284) 71 (213) (1,279) 317 (962) Net gain (loss) from hedging activities 1,247 (119) 1,128 12,188 (3,047) 9,141 Foreign currency translation (3,112) — (3,112) (7,207) — (7,207) Other comprehensive income (loss) $ (2,149) $ (48) $ (2,197) $ 3,702 $ (2,730) $ 972 Nine months ended September 30, 2023 2022 Pre-tax Tax benefit/ After-tax amount Pre-tax Tax benefit/ After-tax amount Defined benefit and other postretirement plans: Net prior service credit (cost) $ (94) $ 23 $ (71) $ (158) $ 39 $ (119) Net gain (loss) 398 (99) 299 (1,225) 304 (921) Benefit plans, net 304 (76) 228 (1,383) 343 (1,040) Net gain (loss) from hedging activities (1,998) 605 (1,393) 36,827 (9,207) 27,620 Foreign currency translation (99) — (99) (17,506) — (17,506) Other comprehensive income (loss) $ (1,793) $ 529 $ (1,264) $ 17,938 $ (8,864) $ 9,074 The following tables present the changes in accumulated other comprehensive income, net of tax, by component for the nine months ended September 30, 2023 and 2022, respectively: Defined benefit Net gain (loss) Foreign Total December 31, 2022 $ (508) $ 24,672 $ (18,172) $ 5,992 Other comprehensive income (loss) before reclassifications 207 12,057 (99) 12,165 Amounts reclassified from accumulated other comprehensive income (1) 21 (13,450) — (13,429) Net current period other comprehensive income (loss) 228 (1,393) (99) (1,264) September 30, 2023 $ (280) $ 23,279 $ (18,271) $ 4,728 December 31, 2021 $ 2,168 $ 290 $ (8,250) $ (5,792) Other comprehensive income (loss) before reclassifications (1,157) 27,148 (17,506) 8,485 Amounts reclassified from accumulated other comprehensive income (1) 117 472 — 589 Net current period other comprehensive income (loss) (1,040) 27,620 (17,506) 9,074 September 30, 2022 $ 1,128 $ 27,910 $ (25,756) $ 3,282 (1) See the following table for details about these reclassifications. Amounts in parentheses indicate debits. The following table presents the reclassifications out of accumulated other comprehensive income for the three and nine months ended September 30, 2023 and 2022, respectively: Details about Accumulated Other Amounts reclassified from Accumulated Other Comprehensive Income (1) Affected line item where Three months ended Nine months ended 2023 2022 2023 2022 Amortization of defined benefit and other postretirement items: Net prior service (credit) cost $ (31) $ (53) $ (94) $ (158) Other (expense) income (2) Net (gain) loss 21 1 48 3 Other (expense) income (2) (10) (52) (46) (155) Total before tax 7 12 25 38 Tax benefit $ (3) $ (40) $ (21) $ (117) Net of tax Gains and losses on cash flow hedges: Interest rate caps $ 6,048 $ (29) $ 17,933 $ (627) Interest expense (1,511) 7 (4,483) 155 Tax (expense) benefit $ 4,537 $ (22) $ 13,450 $ (472) Net of tax Total reclassifications for the period $ 4,534 $ (62) $ 13,429 $ (589) Net of tax (1) Amounts in parentheses indicate debits to profit/loss. (2) These accumulated other comprehensive income (loss) components are components of net periodic pension and other postretirement cost (see Note 14 to these condensed consolidated financial statements for additional details). Treasury Stock Repurchases 2022 Stock Repurchase Program On April 27, 2022, the Board approved a stock repurchase program that authorized the Company to purchase up to $450,000 of the Company’s common stock over the four-year period from the date of approval. Under the plan, the Company is permitted to repurchase shares from time to time for cash in open market transactions or in privately negotiated transactions in accordance with applicable federal securities laws, with the Company determining the timing and the amount of any repurchases based on its evaluation of market conditions, share price and other factors. During the nine months ended September 30, 2023, the Company repurchased 541,494 shares on the open market at an average price of $9.85 per share, for a total of $5,333, excluding brokerage commissions and accrued excise tax. Additionally, in connection with secondary offerings of the Company’s common stock in March and May 2023 , the Company repurchased 7,000,000 shares of its common stock sold in the offerings from the underwriters at a weighted average price of $10.48 per share concurrently with the closing of the offerings, for a total of $73,374, excluding accrued excise tax. As of September 30, 2023, $234,592 was available for additional share repurchases under the program. During the nine months ended September 30, 2023, the Company accrued excise tax of $638 related to these repurchases, net of shares issued under the Company’s equity incentive program (see Note 17 to these condensed consolidated financial statements). This amount is included in accrued liabilities in the condensed consolidated balance sheet and is treated by the Company as a cost of the treasury stock transactions in equity. During the nine months ended September 30, 2022, the Company repurchased 1,970,763 shares on the open market at an average price of $9.82 per share, for a total of $19,356, excluding brokerage commissions. Additionally, in connection with a secondary offering of the Company’s common stock in August 2022, the Company repurchased 6,500,000 shares of its common stock sold in the offering from underwriters at a price of $8.36 per share concurrently with the closing of the offering, for a total of $54,316. Tax Withholdings on Equity Award Vesting In connection with the vesting of restricted stock awards, restricted stock units and performance stock units, shares of common stock may be delivered to the Company by employees to satisfy withholding tax obligations at the instruction of the employee award holders. These transactions, when they occur, are accounted for as stock repurchases by the Company, with the shares returned to treasury stock at a cost representing the payment by the Company of the tax obligations on behalf of the employees in lieu of shares for the vesting unit. There were 315,635 and 32,058 shares delivered to the Company to cover tax payments for the nine months ended September 30, 2023 and 2022, respectively and the fair value of those shares withheld were $3,372 and $332 for the nine months ended September 30, 2023 and 2022, respectively. |
Goodwill
Goodwill | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | 6. Goodwill: The change in the carrying amount of goodwill for the nine months ended September 30, 2023 is summarized as follows: Ecoservices Catalyst Technologies Total Balance as of December 31, 2022 $ 326,589 $ 76,574 $ 403,163 Foreign exchange impact — 205 205 Balance as of September 30, 2023 $ 326,589 $ 76,779 $ 403,368 |
Other Operating Expense, Net
Other Operating Expense, Net | 9 Months Ended |
Sep. 30, 2023 | |
Other Income and Expenses [Abstract] | |
Other Operating Expense, Net | 7. Other Operating Expense, Net: A summary of other operating expense, net is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Amortization expense $ 2,645 $ 2,632 $ 7,924 $ 7,931 Transaction and other related costs 187 1,789 2,811 6,860 Restructuring, integration and business optimization costs (1) 310 2,338 2,438 8,011 Net loss on asset disposals 1,020 468 3,326 1,174 Other, net 148 446 789 1,125 $ 4,310 $ 7,673 $ 17,288 $ 25,101 (1) During the three and nine months ended September 30, 2022 , respectively, the Company’s results were impacted by costs associated with severance charges for certain former executives and employees. |
Inventories, Net
Inventories, Net | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Inventories, Net | 8. Inventories, Net: Inventories, net are classified and valued as follows: September 30, December 31, Finished products and work in process $ 44,406 $ 39,909 Raw materials 3,857 4,453 $ 48,263 $ 44,362 Valued at lower of cost or market: LIFO basis $ 28,157 $ 25,258 Valued at lower of cost and net realizable value: FIFO or average cost basis 20,106 19,104 $ 48,263 $ 44,362 |
Investments in Affiliated Compa
Investments in Affiliated Companies | 9 Months Ended |
Sep. 30, 2023 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investments in Affiliated Companies | 9. Investments in Affiliated Companies: The Company accounts for investments in affiliated companies under the equity method. Affiliated companies accounted for on the equity basis as of September 30, 2023 are as follows: Company Country Percent Zeolyst International USA 50% Zeolyst C.V. Netherlands 50% Following is summarized information of the combined investments (1) : Three months ended Nine months ended 2023 2022 2023 2022 Sales $ 81,115 $ 67,043 $ 236,200 $ 218,389 Gross profit 22,205 17,794 66,776 70,546 Operating income 12,414 10,228 39,916 44,340 Net income 12,617 9,540 42,189 44,448 (1) Summarized information of the combined investments is presented at 100%; the Company’s share of the net assets and net income of affiliates is calculated based on the percent ownership specified in the table above. The Company’s investments in affiliated companies balance as of September 30, 2023 and December 31, 2022 includes net purchase accounting fair value adjustments of $226,215 and $231,017, respectively, related to a prior business combination, consisting primarily of goodwill and intangible assets such as customer relationships, technical know-how and trade names. Consolidated equity in net income from affiliates is net of $1,601 and $4,802 of amortization expense related to purchase accounting fair value adjustments for the three and nine months ended September 30, 2023, respectively. Consolidated equity in net income from affiliates is net of $1,601 and $4,802 of amortization expense related to purchase accounting fair value adjustments for the three and nine months ended September 30, 2022, respectively. |
Property, Plant and Equipment
Property, Plant and Equipment | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | 10. Property, Plant and Equipment: A summary of property, plant and equipment, at cost, and related accumulated depreciation is as follows: September 30, December 31, Land $ 96,686 $ 96,659 Buildings and improvements 83,346 82,061 Machinery and equipment 802,823 751,145 Construction in progress 47,974 56,448 1,030,829 986,313 Less: accumulated depreciation (450,020) (401,424) $ 580,809 $ 584,889 Depreciation expense was $17,773 and $51,920 for the three and nine months ended September 30, 2023, respectively. Depreciation expense was $16,103 and $48,256 for the three and nine months ended September 30, 2022, respectively. |
Long-term Debt
Long-term Debt | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Long-term Debt | 11. Long-term Debt: The summary of long-term debt is as follows: September 30, December 31, Senior Secured Term Loan Facility due June 2028 (the "2021 Term Loan Facility") $ 879,750 $ 886,500 ABL Facility — — Total debt 879,750 886,500 Original issue discount (6,496) (7,472) Deferred financing costs (3,586) (4,158) Total debt, net of original issue discount and deferred financing costs 869,668 874,870 Less: current portion (9,000) (9,000) Total long-term debt, excluding current portion $ 860,668 $ 865,870 In February 2023, the Company amended the 2021 Term Loan Facility to replace LIBOR with SOFR as the benchmark interest rate. Following this amendment, the 2021 Term Loan Facility bears interest at an adjusted term SOFR, which includes a credit spread adjustment of 10 basis points (with a 0.50% minimum floor) plus 2.75% per annum (or, depending on the Company’s first lien net leverage ratio, 2.50%). The interest rate on the 2021 Term Loan Facility was 7.97% as of September 30, 2023. Also in February 2023, the Company amended its senior secured asset-based revolving credit facility (the “ABL Facility”) to replace LIBOR with SOFR as the benchmark interest rate. Following this amendment, the borrowings under the ABL Facility bear interest at a rate equal to an adjusted term SOFR rate or the base rate, which includes a credit spread adjustment of 10 basis points, plus a margin of between 1.25% to 1.75% or 0.25% to 0.75%, respectively. The interest rate on the ABL Facility was 8.75% as of September 30, 2023. Fair Value of Debt The fair value of a financial instrument is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants. As of September 30, 2023 and December 31, 2022, the fair value of the senior secured term loan facility was $875,351 and $870,986, respectively. The fair value is classified as Level 2 based upon the fair value hierarchy (see Note 4 to these condensed consolidated financial statements for further information on fair value measurements). |
Financial Instruments
Financial Instruments | 9 Months Ended |
Sep. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments | 12. Financial Instruments: The Company uses interest rate related derivative instruments to manage its exposure to changes in interest rates on its variable-rate debt instruments. The Company does not speculate using derivative instruments. By using derivative financial instruments to hedge exposures to changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is an asset, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is a liability, the Company owes the counterparty and therefore, the Company is not exposed to the counterparty’s credit risk in those circumstances. The Company minimizes counterparty credit risk in derivative instruments by entering into transactions with high quality counterparties. The derivative instruments entered into by the Company do not contain credit-risk-related contingent features. Market risk is the adverse effect on the value of a derivative instrument that results from a change in interest rates. The market risk associated with the Company’s derivative instruments is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken. Use of Derivative Financial Instruments to Manage Interest Rate Risk. The Company is exposed to fluctuations in interest rates on its senior secured credit facilities. Changes in interest rates will not affect the market value of such debt but will affect the Company’s interest payments over the term of the loans. Likewise, an increase in interest rates could have a material impact on the Company’s condensed consolidated statements of cash flows. The Company hedges the interest rate fluctuations on debt obligations through interest rate cap agreements. The Company records these agreements at fair value as assets or liabilities in its condensed consolidated balance sheets. As the derivatives are designated and qualify as cash flow hedges, the gains or losses on the interest rate cap agreements are recorded in stockholders’ equity as a component of other comprehensive income, net of tax. Reclassifications of the gains and losses on the interest rate cap agreements into earnings are recorded as part of interest expense in the condensed consolidated statements of income as the Company makes its interest payments on the hedged portion of its senior secured credit facilities. Fair value is determined based on estimated amounts that would be received or paid to terminate the contracts at the reporting date based on quoted market prices. The following table provides a summary of the Company’s interest rate cap agreements: Financial instrument Number of instruments In effect as of September 30, 2023 Current notional amount of instruments in effect Annuitized premium of instruments in effect Interest rate cap 4 3 $ 650,000 $ 24,817 The current notional amounts of the three interest rate cap agreements in effect at September 30, 2023 are $250,000, $250,000 and $150,000. The Company entered into a $250,000 interest rate cap to mitigate interest rate volatility from August 2022 to October 2024, a $250,000 interest rate cap agreement to mitigate interest rate volatility from September 2023 to October 2025 and a $150,000 interest rate cap agreement to mitigate interest rate volatility from August 2023 to July 2024. The $150,000 interest rate cap agreement will increase to $175,000 to mitigate interest rate volatility from August 2024 to July 2026. The cap rate in effect at September 30, 2023 for all agreements in effect was 1.00%. The Company has also entered into a forward starting interest rate cap agreement to mitigate interest volatility from November 2024 to October 2026. In February 2023, the Company amended all existing interest rate cap agreements to replace LIBOR with SOFR as the benchmark interest rate, with all other terms of the agreements remaining the same. This amendment changed the previously annuitized premiums on the existing interest rate cap agreements. The fair values of derivative instruments held as of September 30, 2023 and December 31, 2022, respectively are shown below: Balance sheet location September 30, December 31, Derivative assets Derivatives designated as cash flow hedges: Interest rate caps Prepaid and other current assets $ 16,374 $ 18,510 Interest rate caps Other long-term assets 15,804 15,864 Total derivative assets $ 32,178 $ 34,374 Derivative liabilities Derivatives designated as cash flow hedges: Interest rate caps Other long-term liabilities $ — $ 2,071 Total derivative liabilities $ — $ 2,071 The following table shows the effect of the Company’s derivative instruments designated as cash flow hedges on AOCI for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 2022 Location of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Interest rate caps Interest (expense) income $ 7,294 $ 6,048 $ 12,159 $ (29) Nine months ended September 30, 2023 2022 Location of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Interest rate caps Interest (expense) income $ 15,935 $ 17,933 $ 36,200 $ (627) The following table shows the effect of the Company’s cash flow hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2023 and 2022, respectively: Location and amount of gain (loss) recognized in income on cash flow hedging relationships Three months ended Nine months ended 2023 2022 2023 2022 Total amounts of income and expense line items presented in the statement of income in which the effects of cash flow hedges are recorded in interest (expense) income $ (11,811) $ (9,542) $ (30,812) $ (26,880) The effects of cash flow hedging: Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of loss reclassified from AOCI into income 6,048 (29) 17,933 (627) |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 13. Income Taxes: The effective income tax rate for the three months ended September 30, 2023 was 32.3%, compared to 29.6% for the three months ended September 30, 2022. The effective income tax rate for the nine months ended September 30, 2023 was 29.9%, compared to 31.2% for the nine months ended September 30, 2022. The Company’s effective income tax rate fluctuated primarily due to a reduced discrete tax impact related to a stock compensation shortfall and a discrete tax benefit associated with state and local tax law changes. The difference between the U.S. federal statutory income tax rate and the Company’s effective income tax rate for the nine months ended September 30, 2023 was mainly due to state and local taxes, a discrete shortfall tax expense related to stock compensation, a discrete tax expense associated with the recording of accrued penalties and interest associated with historical uncertain tax positions, and a discrete tax benefit connected to state and local tax law changes. The difference between the U.S. federal statutory income tax rate and the Company’s effective income tax rate for the nine months ended September 30, 2022 was mainly due to state and local taxes, a discrete shortfall tax expense related to stock compensation and a discrete tax expense associated with the Employee Retention Credit. |
Benefit Plans
Benefit Plans | 9 Months Ended |
Sep. 30, 2023 | |
Retirement Benefits [Abstract] | |
Benefit Plans | 14. Benefit Plans: The following tables present the components of net periodic expense (benefit) for the Company-sponsored defined benefit pension and postretirement plans, which cover certain employees and retirees located in the U.S. Defined Benefit Pension Plans Three months ended Nine months ended 2023 2022 2023 2022 Interest cost $ 863 $ 681 $ 2,590 $ 1,888 Expected return on plan assets (826) (380) (2,479) (2,599) Settlement loss 22 38 50 38 Net periodic expense (benefit) $ 59 $ 339 $ 161 $ (673) Other Postretirement Benefit Plan Three months ended Nine months ended 2023 2022 2023 2022 Interest cost $ 6 $ 5 $ 18 $ 13 Amortization of prior service credit (31) (53) (94) (158) Amortization of net loss (1) 1 (2) 3 Net periodic benefit $ (26) $ (47) $ (78) $ (142) |
Commitments and Contingent Liab
Commitments and Contingent Liabilities | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingent Liabilities | 15. Commitments and Contingent Liabilities: There is a risk of environmental impact in the Company’s manufacturing operations. The Company’s environmental policies and practices are designed to comply with existing laws and regulations and to minimize the possibility of significant environmental impact. The Company is also subject to various other lawsuits and claims with respect to matters such as governmental regulations, labor and other actions arising out of the normal course of business. All claims that are probable and reasonably estimable have been accrued for in the Company’s condensed consolidated financial statements. When these matters are ultimately concluded and determined, the Company believes that there will be no material adverse effect on its consolidated financial position, results of operations or liquidity. |
Reportable Segments
Reportable Segments | 9 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Reportable Segments | 16. Reportable Segments: Summarized financial information for the Company’s reportable segments is shown in the following table: Three months ended Nine months ended 2023 2022 2023 2022 Sales: Ecoservices $ 147,629 $ 195,674 $ 443,433 $ 542,703 Catalyst Technologies (1) 25,697 36,859 74,877 94,716 Total $ 173,326 $ 232,533 $ 518,310 $ 637,419 Adjusted EBITDA: (2) Ecoservices $ 54,674 $ 64,110 $ 151,598 $ 173,435 Catalyst Technologies (3) 16,360 19,272 54,718 57,676 Adjusted EBITDA from reportable segments $ 71,034 $ 83,382 $ 206,316 $ 231,111 (1) Excludes the Company’s proportionate share of sales from the Zeolyst Joint Venture accounted for using the equity method (see Note 9 to these condensed consolidated financial statements for further information). The proportionate share of sales excluded is $36,958 and $103,721 for the three and nine months ended September 30, 2023, respectively. The proportionate share of sales excluded is $27,773 and $92,656 for the three and nine months ended September 30, 2022, respectively. (2) The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies. (3) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $9,640 for the three months ended September 30, 2023, which includes $4,748 of equity in net income plus $1,601 of amortization of investment in affiliate step-up and $3,291 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $31,270 for the nine months ended September 30, 2023, which includes $16,356 of equity in net income plus $4,802 of amortization of investment in affiliate step-up and $10,112 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $8,704 for the three months ended September 30, 2022, which includes $3,187 of equity in net income plus $1,601 of amortization of investment in affiliate step-up and $3,917 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $34,306 for the nine months ended September 30, 2022, which includes $17,500 of equity in net income plus $4,802 of amortization of investment in affiliate step-up and $12,004 of joint venture depreciation, amortization and interest. A reconciliation of income before income taxes to Adjusted EBITDA is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Reconciliation of income before income taxes to Adjusted EBITDA from reportable segments Income before income taxes $ 24,465 $ 30,291 $ 58,850 $ 70,428 Interest expense, net 11,811 9,542 30,812 26,880 Depreciation and amortization 21,290 19,599 62,456 58,803 Unallocated corporate expenses 3,163 7,945 16,243 23,543 Joint venture depreciation, amortization and interest 3,292 3,917 10,112 12,004 Amortization of investment in affiliate step-up 1,601 1,601 4,802 4,802 Net loss on asset disposals 1,020 468 3,326 1,174 Foreign exchange loss (gain) 774 1,030 (362) 2,179 LIFO (benefit) expense — (436) 2,510 (4) Transaction and other related costs 187 1,789 2,811 6,860 Equity-based compensation 3,477 4,740 12,547 17,419 Restructuring, integration and business optimization expenses 310 2,338 2,438 8,011 Other (356) 558 (229) (988) Adjusted EBITDA from reportable segments $ 71,034 $ 83,382 $ 206,316 $ 231,111 |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | 17. Stock-Based Compensation: The Company has an equity incentive plan under which it grants common stock awards to employees, directors and affiliates of the Company. At September 30, 2023, 9,413,264 shares of common stock were available for issuance under the plan. The Company historically has settled these awards through the issuance of new shares. Beginning on July 1, 2023, the Company commenced reissuing shares from treasury in connection with the settlement of awards under its equity incentive plan. Restricted Stock Units and Performance Stock Units Restricted Stock Units During the nine months ended September 30, 2023, the Company granted 1,195,835 restricted stock units under its equity incentive plan. Each restricted stock unit provides the recipient with the right to receive a share of common stock subject to graded vesting terms based on service, which for the awards granted during the nine months ended September 30, 2023, generally requires approximately one year of service for members of the Company’s board of directors and approximately three years of service for employees. The value of the restricted stock units granted during the nine months ended September 30, 2023 was based on the average of the high and low trading prices of the Company’s common stock on the NYSE on the preceding trading day, in accordance with the Company’s policy for valuing such awards. Compensation expense related to the restricted stock units is recognized on a straight-line basis over the respective vesting period. Performance Stock Units 2023 Grants During the nine months ended September 30, 2023, the Company granted 721,537 performance stock units (at target) under its equity incentive plan. The performance stock units granted during the nine months ended September 30, 2023 provide the recipients with the right to receive shares of common stock dependent on the achievement of a total shareholder return (“TSR”) goal, and are generally subject to the provision of service through the vesting date of the award. The performance period for the TSR goal is measured based on a three-year performance period from January 1, 2023 through December 31, 2025. The TSR goal is based on the Company’s actual TSR percentage increase over the performance period. Depending on the Company’s performance relative to the TSR goal, each performance stock unit award recipient is eligible to receive a percentage of the target number of shares granted to the recipient, ranging from zero to 200%. The performance stock units, to the extent earned, will vest on the date the Compensation Committee of the Company’s Board of Directors (“Compensation Committee”) certifies the achievement of the performance metric for the three-year period ending December 31, 2025, which will occur subsequent to the end of the performance period and after the Company files its annual consolidated financial statements for the year ending December 31, 2025. The TSR goal is considered a market condition as opposed to a vesting condition. Because a market condition is not considered a vesting condition, it is reflected in the grant date fair value of the award and the associated compensation cost based on the fair value of the award is recognized over the performance period, regardless of whether the Company actually achieves the market condition or the level of achievement, as long as service is provided by the recipient. The Company used a Monte Carlo simulation to estimate the $12.28 weighted average fair value of the awards granted during the nine months ended September 30, 2023, with the following weighted average assumptions: Expected dividend yield — % Risk-free interest rate 3.80 % Expected volatility 48.82 % Expected term (in years) 2.96 2020 Grants In March 2023, the Compensation Committee certified the achievement of the performance metrics for the three-year period ended December 31, 2022, related to the performance stock units (“PSUs”) granted during the year ended December 31, 2020. Fifty percent of the target number of such PSUs could be earned depending on performance against a Company-specific financial performance target, and 50% of the target number of such PSUs could be earned depending on performance against a TSR goal, subject to the provision of service through the vesting date of the awards. The Company-specific financial performance target and the TSR goal were measured independently of each other, and each PSU award recipient was eligible to earn a percentage of the target number of shares granted to the recipient, ranging from zero to 200%. The awards vested during the nine months ended September 30, 2023 as follows: 53.3% of target with respect to the portion of the PSU award subject to the Company-specific financial measure, and 56.0% of target with respect to the portion of the PSU award subject to the TSR goal. Award Activity The following table summarizes the activity for the Company’s restricted stock units and performance stock units for the nine months ended September 30, 2023: Restricted Stock Units Performance Stock Units Number of Weighted average grant date fair value (per share) Number of Weighted average grant date fair value (per share) Nonvested as of December 31, 2022 2,464,718 $ 11.73 639,532 (1) $ 16.32 Granted 1,195,835 $ 9.84 721,537 $ 12.28 Vested (1,436,301) $ 11.84 (200,204) $ 20.48 Forfeited (195,334) $ 11.37 (183,864) $ 19.50 Nonvested as of September 30, 2023 2,028,918 $ 10.57 977,001 (1) $ 11.88 (1) Based on target. During the nine months ended September 30, 2023, the Company also granted 5,081 restricted stock awards with a weighted average grant date fair value of $9.84 per share that immediately vested. Stock-Based Compensation Expense For the three months ended September 30, 2023 and 2022, stock-based compensation expense for the Company was $3,477 and $4,740, respectively. The associated income tax benefit recognized in the condensed consolidated statements of income for the three months ended September 30, 2023 and 2022 was $826 and $1,162, respectively. For the nine months ended September 30, 2023 and 2022, stock-based compensation expense for the Company was $12,547 and $17,419, respectively. The associated income tax benefit based on the applicable statutory rate recognized in the condensed consolidated statements of income for the nine months ended September 30, 2023 and 2022 was $2,980 and $4,271, respectively. Performance-based restricted stock awards and performance-based stock options would vest only on the achievement with respect to shares of our common stock of an average closing trading price equal or exceeding, in any ten trading-day period, the lowest amount which, when multiplied by the number of shares of our common stock then held by investment funds affiliated with CCMP Capital Advisors, LP (“CCMP”) and added to the aggregate net proceeds received by investment funds affiliated with CCMP with respect to their shares of capital stock of the Company, would yield a quotient of equal or greater than two when divided by the equity investment in the Company by investment funds affiliated with CCMP (such quotient, the “MOI Target”). On March 7, 2023, all of the outstanding performance-based stock options (284,956 options) and performance-based restricted shares (277,056 shares) that would vest upon the achievement of the MOI Target were canceled due to the failure of the MOI Target to be achieved upon the sale by investment funds affiliated with CCMP of all of their remaining shares of our common stock. No expense had previously been recognized for either the restricted stock awards or the stock options subject to this performance condition, as the condition was not achieved nor was previously considered probable of achievement. In addition to the forfeitures described above, 328,677 vested stock options expired unexercised during the nine months ended September 30, 2023. Cash proceeds received by the Company from the exercise of stock options were not material for the nine months ended September 30, 2023. |
Earnings per Share
Earnings per Share | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Earnings per Share | 18. Earnings per Share: Basic earnings per share is calculated as income available to common stockholders, divided by the weighted average number of common shares outstanding during the period. The weighted average number of common shares outstanding during the period for the computation of basic earnings per share excludes restricted stock awards that have legally been issued but are nonvested during the period, as the sale of these shares is prohibited pending satisfaction of certain vesting conditions by the award recipients in order to earn the rights to the shares. Diluted earnings per share is calculated as income available to common stockholders, divided by the weighted average number of common and potential common shares outstanding during the period, if dilutive. Potential common shares reflect (1) unvested restricted stock awards and restricted stock units with service vesting conditions, (2) performance stock units with vesting conditions considered probable of achievement and (3) options to purchase common stock, all of which have been included in the diluted earnings per share calculation using the treasury stock method. The reconciliation from basic to diluted weighted average shares outstanding is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Weighted average shares outstanding – Basic 116,446,085 132,622,105 119,042,161 136,115,598 Dilutive effect of unvested common shares and restricted stock units with service conditions, performance stock units considered probable of vesting and assumed stock option exercises and conversions 928,262 1,474,734 1,374,971 1,550,617 Weighted average shares outstanding – Diluted 117,374,347 134,096,839 120,417,132 137,666,215 Basic and diluted income per share are calculated as follows: Three months ended Nine months ended 2023 2022 2023 2022 Numerator: Net income $ 16,574 $ 21,325 $ 41,225 $ 48,445 Denominator: Weighted average shares outstanding – Basic 116,446,085 132,622,105 119,042,161 136,115,598 Weighted average shares outstanding – Diluted 117,374,347 134,096,839 120,417,132 137,666,215 Net income per share: Basic income per share $ 0.14 $ 0.16 $ 0.35 $ 0.36 Diluted income per share $ 0.14 $ 0.16 $ 0.34 $ 0.35 The table below presents the details of the Company’s weighted average equity-based awards outstanding during each respective period that were excluded from the calculation of diluted earnings per share: Three months ended Nine months ended 2023 2022 2023 2022 Restricted stock awards with performance only targets not achieved — 505,439 65,966 574,048 Stock options with performance only targets not achieved — 300,788 68,890 316,187 Anti-dilutive restricted stock units and performance stock units — 487,322 — 19,306 Anti-dilutive stock options 454,461 751,539 556,114 788,509 Restricted stock awards and stock options with performance only vesting conditions were not included in the dilution calculation, as the performance targets have not been achieved nor were probable of achievement as of the end of the respective periods. These awards and stock options were canceled on March 7, 2023 (see Note 17 to these condensed consolidated financial statements for additional information). Certain stock options to purchase shares of common stock were excluded from the computation of diluted earnings per share for the respective periods because the options’ exercise price was greater than the average market price of the common shares. These stock options and anti-dilutive awards are not included in the dilution calculation, as their inclusion would have the effect of increasing diluted income per share or reducing diluted loss per share. |
Supplemental Cash Flow Informat
Supplemental Cash Flow Information | 9 Months Ended |
Sep. 30, 2023 | |
Supplemental Cash Flow Elements [Abstract] | |
Supplemental Cash Flow Information | 19. Supplemental Cash Flow Information: The following table presents supplemental cash flow information for the Company: Nine months ended 2023 2022 Cash paid during the period for: Income taxes, net of refunds $ 19,019 $ 24,367 Interest (1) 28,466 24,390 Non-cash investing activity: Capital expenditures acquired on account but unpaid as of the period end 589 4,993 Non-cash financing activity: Accrued excise tax on share repurchases (Note 5) 638 — Right-of-use assets obtained in exchange for new lease liabilities (non-cash): Operating leases 8,048 6,187 (1) Cash paid for interest is shown net of capitalized interest and includes the cash received or paid on the Company’s interest rate cap agreements designated as cash flow hedges for the periods presented (see Note 12 to these condensed consolidated financial statements for details). |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | 20. Subsequent Events: The Company has evaluated subsequent events since the balance sheet date and determined that there are no additional items to disclose. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||||||||
Net income | $ 16,574 | $ 26,122 | $ (1,471) | $ 21,325 | $ 19,245 | $ 7,875 | $ 41,225 | $ 48,445 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Sep. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Background and Basis of Prese_2
Background and Basis of Presentation (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The condensed consolidated financial statements included herein are unaudited. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations for interim reporting. In the opinion of management, all adjustments of a normal and recurring nature necessary to state fairly the financial position and results of operations have been included. The results of operations are not necessarily indicative of the expected results for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. |
Recently Adopted Accounting Standards | Recently Adopted Accounting Standards In October 2023, the Financial Accounting Standards Board (“FASB”) issued guidance to amend either presentation or disclosure requirements related to fourteen subtopics in the FASB Accounting Standards Codification, that are currently in the SEC Regulation S-X or Regulation S-K. The new guidance was issued in response to the SEC’s ruling on disclosure simplification. For entities subject to existing SEC disclosure requirements, the effective date of each amendment of the topics will be the date that the SEC removes the related disclosure from Regulation S-X or Regulation S-K. The guidance must be applied prospectively, with no early adoption permitted for entities subject to those existing SEC disclosures. The Company is currently evaluating the impact of the new guidance as it pertains to the fourteen subtopics that would impact the business and will apply prospectively once in effect. In August 2023, the FASB issued guidance for entities that meet the definition of a joint venture or a corporate joint venture, to adopt a new basis of accounting upon the formation of the joint venture. The new guidance requires the initial measurement of contributed net assets and liabilities at fair value on the formation date, recognition of goodwill for the difference between the fair value of the joint venture’s equity and net assets, and disclosures about the nature and financial impact of the transaction. The new guidance requires prospective application and is effective for all joint ventures that are formed on or after January 1, 2025, with early adoption permitted. Joint ventures that formed before January 1, 2025 may elect to retrospectively apply the new guidance. The Company will apply the guidance to any new joint ventures formed after the effective date. In March 2020 and January 2021, the FASB issued guidance to address certain accounting consequences from the anticipated transition from the use of the London Interbank Offered Rate (“LIBOR”) and other interbank offered rates to alternative reference rates. The new guidance contains practical expedients for reference rate reform related activities that impact debt, leases, derivatives and other contracts. The guidance is optional and may be elected over time as reference rate reform activities occur. The time period through which the practical expedients provided in the guidance is available was set to expire on December 31, 2022, but was extended through December 31, 2024 by the FASB in December 2022. During the year ended December 31, 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index of the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. In February 2023, the Company amended the 2021 Term Loan Facility (as defined below), the ABL Facility (as defined below) and all existing interest rate caps agreements to replace LIBOR with a secured overnight financing rate (“SOFR”) as the benchmark interest rate. See Note 11 and Note 12 to these condensed consolidated financial statements for additional information. The Company utilized the practical expedients under the guidance with respect to the transition of its debt facilities and interest rate hedging arrangements to SOFR, with no impact to its condensed consolidated financial statements. In October 2021, the FASB issued guidance that requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with revenue recognition guidance. Under current GAAP, contract assets and contract liabilities acquired in a business combination are recorded by the acquirer at fair value. The new guidance creates an exception to the general recognition and measurement principles related to business combinations, and is expected to result in the acquirer recognizing contract assets and liabilities at the same amounts recorded by the acquiree. The new guidance is effective for business combinations occurring during fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, with early adoption permitted. The Company adopted the new guidance effective January 1, 2023 as required, and will apply the guidance prospectively to business combinations that occur after the adoption date. |
Derivative contracts | Derivative contracts Derivative assets and liabilities can be exchange-traded or traded over-the-counter (“OTC”). The Company generally values exchange-traded derivatives using models that calibrate to market transactions and eliminate timing differences between the closing price of the exchange-traded derivatives and their underlying instruments. OTC derivatives are valued using market transactions and other market evidence whenever possible, including market-based inputs to models, model calibration to market transactions, broker or dealer quotations or alternative pricing sources with reasonable levels of price transparency. When models are used, the selection of a particular model to value an OTC derivative depends on the contractual terms of, and specific risks inherent in, the instrument as well as the availability of pricing information in the market. The Company generally uses similar models to value similar instruments. Valuation models require a variety of inputs, including contractual terms, market prices and rates, forward curves, measures of volatility, and correlations of such inputs. For OTC derivatives that trade in liquid markets, such as forward contracts, swaps and options, model inputs can generally be corroborated by observable market data by correlation or other means, and model selection does not involve significant management judgment. As of September 30, 2023, th e Company had interest rate c aps th at were fair valued using Level 2 inputs. In addition, the Company applies a credit valuation adjustment to reflect credit risk which is calculated based on credit default swaps. To the extent that the Company’s net exposure under a specific master agreement is an asset, the Company utilizes the counterparty’s default swap rate. If the net exposure under a specific master agreement is a liability, the Company utilizes a default swap rate comparable to Ecovyst. The credit valuation adjustment is added to the discounted fair value to reflect the exit price that a market participant would be willing to receive to assume the Company’s liabilities or that a market participant would be willing to pay for the Company’s assets. |
Background and Basis of Prese_3
Background and Basis of Presentation (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Correction of an Error | As a result, the presentation of accumulated other comprehensive income (loss) in Note 5 was corrected by revising the opening balances as follows: Defined benefit and other postretirement plans Net gain (loss) from hedging activities Foreign currency translation As reported, December 31, 2021 $ 14,808 $ 2,254 $ (22,854) Correction to opening balances (12,640) (1,964) 14,604 Revised, December 31, 2021 $ 2,168 $ 290 $ (8,250) As reported, December 31, 2022 $ 12,132 $ 26,636 $ (32,776) Correction to opening balances (12,640) (1,964) 14,604 Revised, December 31, 2022 $ (508) $ 24,672 $ (18,172) |
Revenue from Contracts with C_2
Revenue from Contracts with Customers (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The Company’s portfolio of products is integrated into a variety of end uses, which are described in the table below. Key End Uses Key Products Clean fuels, emission control & other • Refining hydrocracking catalysts • Emission control catalysts • Catalysts used in production of renewable fuels • Catalyst activation • Aluminum sulfate solution • Ammonium bisulfite solution Polymers & engineered plastics • Catalysts for high-density polyethylene and chemicals syntheses • Antiblocks for film packaging • Niche custom catalyst Regeneration and treatment services • Sulfuric acid regeneration services • Treatment services Industrial, mining & automotive • Sulfur derivatives for industrial production • Sulfuric acid for mining • Sulfuric derivatives for nylon production The following tables disaggregate the Company’s sales, by segment and end uses, for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 8,393 $ — $ 8,393 Polymers & engineered plastics — 25,697 25,697 Regeneration and treatment services (1) 87,692 — 87,692 Industrial, mining & automotive 51,544 — 51,544 Total segment sales $ 147,629 $ 25,697 $ 173,326 Three months ended September 30, 2022 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 7,991 $ — $ 7,991 Polymers & engineered plastics — 36,859 36,859 Regeneration and treatment services (1) 92,676 — 92,676 Industrial, mining & automotive 95,007 — 95,007 Total segment sales $ 195,674 $ 36,859 $ 232,533 Nine months ended September 30, 2023 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 21,559 $ — $ 21,559 Polymers & engineered plastics — 74,877 74,877 Regeneration and treatment services (1) 274,529 — 274,529 Industrial, mining & automotive 147,345 — 147,345 Total segment sales $ 443,433 $ 74,877 $ 518,310 Nine months ended September 30, 2022 Ecoservices Catalyst Technologies (2) Total Clean fuels, emission control & other $ 22,474 $ — $ 22,474 Polymers & engineered plastics — 94,716 94,716 Regeneration and treatment services (1) 253,793 — 253,793 Industrial, mining & automotive 266,436 — 266,436 Total segment sales $ 542,703 $ 94,716 $ 637,419 (1) As described in Note 1 to these condensed consolidated financial statements, the Company experiences seasonal s ales fluctuations to customers in the regeneration services product group. (2) Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 9 to these condensed consolidated financial statements for further information). |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measured on Recurring Basis | The following tables present information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of September 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. September 30, Quoted Prices in Significant Other Significant Derivative assets: Interest rate caps (Note 12) $ 32,178 $ — $ 32,178 $ — December 31, Quoted Prices in Significant Other Significant Derivative assets: Interest rate caps (Note 12) $ 34,374 $ — $ 34,374 $ — Derivative liabilities: Interest rate caps (Note 12) $ 2,071 $ — $ 2,071 $ — |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Pre-tax and After-tax Components of Other Comprehensive Income (Loss) | The following tables present the tax effects of each component of other comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 2022 Pre-tax Tax benefit/ After-tax amount Pre-tax Tax benefit/ After-tax amount Defined benefit and other postretirement plans: Net prior service credit (cost) $ (31) $ 8 $ (23) $ (53) $ 13 $ (40) Net gain (loss) (253) 63 (190) (1,226) 304 (922) Benefit plans, net (284) 71 (213) (1,279) 317 (962) Net gain (loss) from hedging activities 1,247 (119) 1,128 12,188 (3,047) 9,141 Foreign currency translation (3,112) — (3,112) (7,207) — (7,207) Other comprehensive income (loss) $ (2,149) $ (48) $ (2,197) $ 3,702 $ (2,730) $ 972 Nine months ended September 30, 2023 2022 Pre-tax Tax benefit/ After-tax amount Pre-tax Tax benefit/ After-tax amount Defined benefit and other postretirement plans: Net prior service credit (cost) $ (94) $ 23 $ (71) $ (158) $ 39 $ (119) Net gain (loss) 398 (99) 299 (1,225) 304 (921) Benefit plans, net 304 (76) 228 (1,383) 343 (1,040) Net gain (loss) from hedging activities (1,998) 605 (1,393) 36,827 (9,207) 27,620 Foreign currency translation (99) — (99) (17,506) — (17,506) Other comprehensive income (loss) $ (1,793) $ 529 $ (1,264) $ 17,938 $ (8,864) $ 9,074 The following tables present the changes in accumulated other comprehensive income, net of tax, by component for the nine months ended September 30, 2023 and 2022, respectively: Defined benefit Net gain (loss) Foreign Total December 31, 2022 $ (508) $ 24,672 $ (18,172) $ 5,992 Other comprehensive income (loss) before reclassifications 207 12,057 (99) 12,165 Amounts reclassified from accumulated other comprehensive income (1) 21 (13,450) — (13,429) Net current period other comprehensive income (loss) 228 (1,393) (99) (1,264) September 30, 2023 $ (280) $ 23,279 $ (18,271) $ 4,728 December 31, 2021 $ 2,168 $ 290 $ (8,250) $ (5,792) Other comprehensive income (loss) before reclassifications (1,157) 27,148 (17,506) 8,485 Amounts reclassified from accumulated other comprehensive income (1) 117 472 — 589 Net current period other comprehensive income (loss) (1,040) 27,620 (17,506) 9,074 September 30, 2022 $ 1,128 $ 27,910 $ (25,756) $ 3,282 (1) See the following table for details about these reclassifications. Amounts in parentheses indicate debits. |
Reclassifications out of Accumulated Other Comprehensive Income | The following table presents the reclassifications out of accumulated other comprehensive income for the three and nine months ended September 30, 2023 and 2022, respectively: Details about Accumulated Other Amounts reclassified from Accumulated Other Comprehensive Income (1) Affected line item where Three months ended Nine months ended 2023 2022 2023 2022 Amortization of defined benefit and other postretirement items: Net prior service (credit) cost $ (31) $ (53) $ (94) $ (158) Other (expense) income (2) Net (gain) loss 21 1 48 3 Other (expense) income (2) (10) (52) (46) (155) Total before tax 7 12 25 38 Tax benefit $ (3) $ (40) $ (21) $ (117) Net of tax Gains and losses on cash flow hedges: Interest rate caps $ 6,048 $ (29) $ 17,933 $ (627) Interest expense (1,511) 7 (4,483) 155 Tax (expense) benefit $ 4,537 $ (22) $ 13,450 $ (472) Net of tax Total reclassifications for the period $ 4,534 $ (62) $ 13,429 $ (589) Net of tax (1) Amounts in parentheses indicate debits to profit/loss. (2) These accumulated other comprehensive income (loss) components are components of net periodic pension and other postretirement cost (see Note 14 to these condensed consolidated financial statements for additional details). |
Goodwill (Tables)
Goodwill (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Change in Carrying Amount of Goodwill | The change in the carrying amount of goodwill for the nine months ended September 30, 2023 is summarized as follows: Ecoservices Catalyst Technologies Total Balance as of December 31, 2022 $ 326,589 $ 76,574 $ 403,163 Foreign exchange impact — 205 205 Balance as of September 30, 2023 $ 326,589 $ 76,779 $ 403,368 |
Other Operating Expense, Net (T
Other Operating Expense, Net (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Other Income and Expenses [Abstract] | |
Summary of Other Operating Expense, Net | A summary of other operating expense, net is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Amortization expense $ 2,645 $ 2,632 $ 7,924 $ 7,931 Transaction and other related costs 187 1,789 2,811 6,860 Restructuring, integration and business optimization costs (1) 310 2,338 2,438 8,011 Net loss on asset disposals 1,020 468 3,326 1,174 Other, net 148 446 789 1,125 $ 4,310 $ 7,673 $ 17,288 $ 25,101 (1) During the three and nine months ended September 30, 2022 , respectively, the Company’s results were impacted by costs associated with severance charges for certain former executives and employees. |
Inventories, Net (Tables)
Inventories, Net (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Inventories, Net | Inventories, net are classified and valued as follows: September 30, December 31, Finished products and work in process $ 44,406 $ 39,909 Raw materials 3,857 4,453 $ 48,263 $ 44,362 Valued at lower of cost or market: LIFO basis $ 28,157 $ 25,258 Valued at lower of cost and net realizable value: FIFO or average cost basis 20,106 19,104 $ 48,263 $ 44,362 |
Investments in Affiliated Com_2
Investments in Affiliated Companies (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Ownership Percentage and Summarized Income Statement | Affiliated companies accounted for on the equity basis as of September 30, 2023 are as follows: Company Country Percent Zeolyst International USA 50% Zeolyst C.V. Netherlands 50% Following is summarized information of the combined investments (1) : Three months ended Nine months ended 2023 2022 2023 2022 Sales $ 81,115 $ 67,043 $ 236,200 $ 218,389 Gross profit 22,205 17,794 66,776 70,546 Operating income 12,414 10,228 39,916 44,340 Net income 12,617 9,540 42,189 44,448 (1) Summarized information of the combined investments is presented at 100%; the Company’s share of the net assets and net income of affiliates is calculated based on the percent ownership specified in the table above. |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Property, Plant and Equipment [Abstract] | |
Summary of Property, Plant and Equipment | A summary of property, plant and equipment, at cost, and related accumulated depreciation is as follows: September 30, December 31, Land $ 96,686 $ 96,659 Buildings and improvements 83,346 82,061 Machinery and equipment 802,823 751,145 Construction in progress 47,974 56,448 1,030,829 986,313 Less: accumulated depreciation (450,020) (401,424) $ 580,809 $ 584,889 |
Long-term Debt (Tables)
Long-term Debt (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Summary of Long-Term Debt | The summary of long-term debt is as follows: September 30, December 31, Senior Secured Term Loan Facility due June 2028 (the "2021 Term Loan Facility") $ 879,750 $ 886,500 ABL Facility — — Total debt 879,750 886,500 Original issue discount (6,496) (7,472) Deferred financing costs (3,586) (4,158) Total debt, net of original issue discount and deferred financing costs 869,668 874,870 Less: current portion (9,000) (9,000) Total long-term debt, excluding current portion $ 860,668 $ 865,870 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Interest Rate Cap Agreements | The following table provides a summary of the Company’s interest rate cap agreements: Financial instrument Number of instruments In effect as of September 30, 2023 Current notional amount of instruments in effect Annuitized premium of instruments in effect Interest rate cap 4 3 $ 650,000 $ 24,817 |
Fair Values of Derivative Instruments Held | The fair values of derivative instruments held as of September 30, 2023 and December 31, 2022, respectively are shown below: Balance sheet location September 30, December 31, Derivative assets Derivatives designated as cash flow hedges: Interest rate caps Prepaid and other current assets $ 16,374 $ 18,510 Interest rate caps Other long-term assets 15,804 15,864 Total derivative assets $ 32,178 $ 34,374 Derivative liabilities Derivatives designated as cash flow hedges: Interest rate caps Other long-term liabilities $ — $ 2,071 Total derivative liabilities $ — $ 2,071 |
Effect of Derivative Instruments Designated as Hedges on Other Comprehensive Income | The following table shows the effect of the Company’s derivative instruments designated as cash flow hedges on AOCI for the three and nine months ended September 30, 2023 and 2022, respectively: Three months ended September 30, 2023 2022 Location of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Interest rate caps Interest (expense) income $ 7,294 $ 6,048 $ 12,159 $ (29) Nine months ended September 30, 2023 2022 Location of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Amount of gain (loss) recognized in OCI on derivatives Amount of gain (loss) reclassified from AOCI into income Interest rate caps Interest (expense) income $ 15,935 $ 17,933 $ 36,200 $ (627) |
Cash Flow Hedge Impact on Income Statement | The following table shows the effect of the Company’s cash flow hedge accounting on the condensed consolidated statements of income for the three and nine months ended September 30, 2023 and 2022, respectively: Location and amount of gain (loss) recognized in income on cash flow hedging relationships Three months ended Nine months ended 2023 2022 2023 2022 Total amounts of income and expense line items presented in the statement of income in which the effects of cash flow hedges are recorded in interest (expense) income $ (11,811) $ (9,542) $ (30,812) $ (26,880) The effects of cash flow hedging: Gain (loss) on cash flow hedging relationships: Interest contracts: Amount of loss reclassified from AOCI into income 6,048 (29) 17,933 (627) |
Benefit Plans (Tables)
Benefit Plans (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Retirement Benefits [Abstract] | |
Components of Net Periodic Expense (Benefit) | Defined Benefit Pension Plans Three months ended Nine months ended 2023 2022 2023 2022 Interest cost $ 863 $ 681 $ 2,590 $ 1,888 Expected return on plan assets (826) (380) (2,479) (2,599) Settlement loss 22 38 50 38 Net periodic expense (benefit) $ 59 $ 339 $ 161 $ (673) Other Postretirement Benefit Plan Three months ended Nine months ended 2023 2022 2023 2022 Interest cost $ 6 $ 5 $ 18 $ 13 Amortization of prior service credit (31) (53) (94) (158) Amortization of net loss (1) 1 (2) 3 Net periodic benefit $ (26) $ (47) $ (78) $ (142) |
Reportable Segments (Tables)
Reportable Segments (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Summary Financial Information by Reportable Segment | Summarized financial information for the Company’s reportable segments is shown in the following table: Three months ended Nine months ended 2023 2022 2023 2022 Sales: Ecoservices $ 147,629 $ 195,674 $ 443,433 $ 542,703 Catalyst Technologies (1) 25,697 36,859 74,877 94,716 Total $ 173,326 $ 232,533 $ 518,310 $ 637,419 Adjusted EBITDA: (2) Ecoservices $ 54,674 $ 64,110 $ 151,598 $ 173,435 Catalyst Technologies (3) 16,360 19,272 54,718 57,676 Adjusted EBITDA from reportable segments $ 71,034 $ 83,382 $ 206,316 $ 231,111 (1) Excludes the Company’s proportionate share of sales from the Zeolyst Joint Venture accounted for using the equity method (see Note 9 to these condensed consolidated financial statements for further information). The proportionate share of sales excluded is $36,958 and $103,721 for the three and nine months ended September 30, 2023, respectively. The proportionate share of sales excluded is $27,773 and $92,656 for the three and nine months ended September 30, 2022, respectively. (2) The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies. (3) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $9,640 for the three months ended September 30, 2023, which includes $4,748 of equity in net income plus $1,601 of amortization of investment in affiliate step-up and $3,291 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $31,270 for the nine months ended September 30, 2023, which includes $16,356 of equity in net income plus $4,802 of amortization of investment in affiliate step-up and $10,112 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $8,704 for the three months ended September 30, 2022, which includes $3,187 of equity in net income plus $1,601 of amortization of investment in affiliate step-up and $3,917 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $34,306 for the nine months ended September 30, 2022, which includes $17,500 of equity in net income plus $4,802 of amortization of investment in affiliate step-up and $12,004 of joint venture depreciation, amortization and interest. |
Reconciliation of Net Income to Segment Adjusted EBITDA | A reconciliation of income before income taxes to Adjusted EBITDA is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Reconciliation of income before income taxes to Adjusted EBITDA from reportable segments Income before income taxes $ 24,465 $ 30,291 $ 58,850 $ 70,428 Interest expense, net 11,811 9,542 30,812 26,880 Depreciation and amortization 21,290 19,599 62,456 58,803 Unallocated corporate expenses 3,163 7,945 16,243 23,543 Joint venture depreciation, amortization and interest 3,292 3,917 10,112 12,004 Amortization of investment in affiliate step-up 1,601 1,601 4,802 4,802 Net loss on asset disposals 1,020 468 3,326 1,174 Foreign exchange loss (gain) 774 1,030 (362) 2,179 LIFO (benefit) expense — (436) 2,510 (4) Transaction and other related costs 187 1,789 2,811 6,860 Equity-based compensation 3,477 4,740 12,547 17,419 Restructuring, integration and business optimization expenses 310 2,338 2,438 8,011 Other (356) 558 (229) (988) Adjusted EBITDA from reportable segments $ 71,034 $ 83,382 $ 206,316 $ 231,111 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Valuation Assumptions | The Company used a Monte Carlo simulation to estimate the $12.28 weighted average fair value of the awards granted during the nine months ended September 30, 2023, with the following weighted average assumptions: Expected dividend yield — % Risk-free interest rate 3.80 % Expected volatility 48.82 % Expected term (in years) 2.96 |
Activity of Restricted Stock Units | The following table summarizes the activity for the Company’s restricted stock units and performance stock units for the nine months ended September 30, 2023: Restricted Stock Units Performance Stock Units Number of Weighted average grant date fair value (per share) Number of Weighted average grant date fair value (per share) Nonvested as of December 31, 2022 2,464,718 $ 11.73 639,532 (1) $ 16.32 Granted 1,195,835 $ 9.84 721,537 $ 12.28 Vested (1,436,301) $ 11.84 (200,204) $ 20.48 Forfeited (195,334) $ 11.37 (183,864) $ 19.50 Nonvested as of September 30, 2023 2,028,918 $ 10.57 977,001 (1) $ 11.88 (1) Based on target. |
Activity of Performance Stock Units | The following table summarizes the activity for the Company’s restricted stock units and performance stock units for the nine months ended September 30, 2023: Restricted Stock Units Performance Stock Units Number of Weighted average grant date fair value (per share) Number of Weighted average grant date fair value (per share) Nonvested as of December 31, 2022 2,464,718 $ 11.73 639,532 (1) $ 16.32 Granted 1,195,835 $ 9.84 721,537 $ 12.28 Vested (1,436,301) $ 11.84 (200,204) $ 20.48 Forfeited (195,334) $ 11.37 (183,864) $ 19.50 Nonvested as of September 30, 2023 2,028,918 $ 10.57 977,001 (1) $ 11.88 (1) Based on target. |
Earnings per Share (Tables)
Earnings per Share (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Reconciliation from Basic to Diluted Weighted Average Shares Outstanding | The reconciliation from basic to diluted weighted average shares outstanding is as follows: Three months ended Nine months ended 2023 2022 2023 2022 Weighted average shares outstanding – Basic 116,446,085 132,622,105 119,042,161 136,115,598 Dilutive effect of unvested common shares and restricted stock units with service conditions, performance stock units considered probable of vesting and assumed stock option exercises and conversions 928,262 1,474,734 1,374,971 1,550,617 Weighted average shares outstanding – Diluted 117,374,347 134,096,839 120,417,132 137,666,215 |
Calculation of Basic and Diluted Earnings per Share | Basic and diluted income per share are calculated as follows: Three months ended Nine months ended 2023 2022 2023 2022 Numerator: Net income $ 16,574 $ 21,325 $ 41,225 $ 48,445 Denominator: Weighted average shares outstanding – Basic 116,446,085 132,622,105 119,042,161 136,115,598 Weighted average shares outstanding – Diluted 117,374,347 134,096,839 120,417,132 137,666,215 Net income per share: Basic income per share $ 0.14 $ 0.16 $ 0.35 $ 0.36 Diluted income per share $ 0.14 $ 0.16 $ 0.34 $ 0.35 |
Anti-dilutive Shares | The table below presents the details of the Company’s weighted average equity-based awards outstanding during each respective period that were excluded from the calculation of diluted earnings per share: Three months ended Nine months ended 2023 2022 2023 2022 Restricted stock awards with performance only targets not achieved — 505,439 65,966 574,048 Stock options with performance only targets not achieved — 300,788 68,890 316,187 Anti-dilutive restricted stock units and performance stock units — 487,322 — 19,306 Anti-dilutive stock options 454,461 751,539 556,114 788,509 |
Supplemental Cash Flow Inform_2
Supplemental Cash Flow Information (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Supplemental Cash Flow Elements [Abstract] | |
Schedule of Cash Flow, Supplemental Disclosures | The following table presents supplemental cash flow information for the Company: Nine months ended 2023 2022 Cash paid during the period for: Income taxes, net of refunds $ 19,019 $ 24,367 Interest (1) 28,466 24,390 Non-cash investing activity: Capital expenditures acquired on account but unpaid as of the period end 589 4,993 Non-cash financing activity: Accrued excise tax on share repurchases (Note 5) 638 — Right-of-use assets obtained in exchange for new lease liabilities (non-cash): Operating leases 8,048 6,187 (1) Cash paid for interest is shown net of capitalized interest and includes the cash received or paid on the Company’s interest rate cap agreements designated as cash flow hedges for the periods presented (see Note 12 to these condensed consolidated financial statements for details). |
Background and Basis of Prese_4
Background and Basis of Presentation - Narrative (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 USD ($) | Sep. 30, 2022 USD ($) | Sep. 30, 2023 USD ($) reporting_unit | Sep. 30, 2022 USD ($) | |
Reclassification [Line Items] | ||||
Number of reporting units | reporting_unit | 2 | |||
Interest expense, net | $ 11,811 | $ 9,542 | $ 30,812 | $ 26,880 |
Correction to opening balances | Cash flow hedging | ||||
Reclassification [Line Items] | ||||
Interest expense, net | $ 1,390 |
Background and Basis of Prese_5
Background and Basis of Presentation - Correction of an Error (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 |
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | $ 677,856 | $ 667,764 | $ 674,151 | $ 707,229 | $ 739,525 | $ 778,184 | $ 765,631 | $ 740,737 |
Defined benefit and other postretirement plans | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | (280) | (508) | 1,128 | 2,168 | ||||
Defined benefit and other postretirement plans | Previously Reported | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | 12,132 | 14,808 | ||||||
Defined benefit and other postretirement plans | Correction to opening balances | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | (12,640) | (12,640) | ||||||
Net gain (loss) from hedging activities | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | 23,279 | 24,672 | 27,910 | 290 | ||||
Net gain (loss) from hedging activities | Previously Reported | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | 26,636 | 2,254 | ||||||
Net gain (loss) from hedging activities | Correction to opening balances | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | (1,964) | (1,964) | ||||||
Foreign currency translation | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | $ (18,271) | (18,172) | $ (25,756) | (8,250) | ||||
Foreign currency translation | Previously Reported | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | (32,776) | (22,854) | ||||||
Foreign currency translation | Correction to opening balances | ||||||||
Reclassification [Line Items] | ||||||||
Accumulated other comprehensive income (loss) | $ 14,604 | $ 14,604 |
Revenue from Contracts with C_3
Revenue from Contracts with Customers - Disaggregated Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Disaggregated Revenue | ||||
Total segment sales | $ 173,326 | $ 232,533 | $ 518,310 | $ 637,419 |
Clean fuels, emission control & other | ||||
Disaggregated Revenue | ||||
Total segment sales | 8,393 | 7,991 | 21,559 | 22,474 |
Polymers & engineered plastics | ||||
Disaggregated Revenue | ||||
Total segment sales | 25,697 | 36,859 | 74,877 | 94,716 |
Regeneration and treatment services | ||||
Disaggregated Revenue | ||||
Total segment sales | 87,692 | 92,676 | 274,529 | 253,793 |
Industrial, mining & automotive | ||||
Disaggregated Revenue | ||||
Total segment sales | 51,544 | 95,007 | 147,345 | 266,436 |
Ecoservices | ||||
Disaggregated Revenue | ||||
Total segment sales | 147,629 | 195,674 | 443,433 | 542,703 |
Ecoservices | Clean fuels, emission control & other | ||||
Disaggregated Revenue | ||||
Total segment sales | 8,393 | 7,991 | 21,559 | 22,474 |
Ecoservices | Polymers & engineered plastics | ||||
Disaggregated Revenue | ||||
Total segment sales | 0 | 0 | 0 | 0 |
Ecoservices | Regeneration and treatment services | ||||
Disaggregated Revenue | ||||
Total segment sales | 87,692 | 92,676 | 274,529 | 253,793 |
Ecoservices | Industrial, mining & automotive | ||||
Disaggregated Revenue | ||||
Total segment sales | 51,544 | 95,007 | 147,345 | 266,436 |
Catalyst Technologies | ||||
Disaggregated Revenue | ||||
Total segment sales | 25,697 | 36,859 | 74,877 | 94,716 |
Catalyst Technologies | Clean fuels, emission control & other | ||||
Disaggregated Revenue | ||||
Total segment sales | 0 | 0 | 0 | 0 |
Catalyst Technologies | Polymers & engineered plastics | ||||
Disaggregated Revenue | ||||
Total segment sales | 25,697 | 36,859 | 74,877 | 94,716 |
Catalyst Technologies | Regeneration and treatment services | ||||
Disaggregated Revenue | ||||
Total segment sales | 0 | 0 | 0 | 0 |
Catalyst Technologies | Industrial, mining & automotive | ||||
Disaggregated Revenue | ||||
Total segment sales | $ 0 | $ 0 | $ 0 | $ 0 |
Fair Value Measurements - Hiera
Fair Value Measurements - Hierarchy of the Valuation Techniques (Details) - Recurring - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Derivative assets: | ||
Interest rate caps | $ 32,178 | $ 34,374 |
Derivative liabilities: | ||
Derivative Liability | 2,071 | |
Quoted Prices in Active Markets (Level 1) | ||
Derivative assets: | ||
Interest rate caps | 0 | 0 |
Derivative liabilities: | ||
Derivative Liability | 0 | |
Significant Other Observable Inputs (Level 2) | ||
Derivative assets: | ||
Interest rate caps | 32,178 | 34,374 |
Derivative liabilities: | ||
Derivative Liability | 2,071 | |
Significant Unobservable Inputs (Level 3) | ||
Derivative assets: | ||
Interest rate caps | $ 0 | 0 |
Derivative liabilities: | ||
Derivative Liability | $ 0 |
Stockholders' Equity - Pre-tax
Stockholders' Equity - Pre-tax and After-tax Components of Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | $ (2,149) | $ 3,702 | $ (1,793) | $ 17,938 | ||||
Tax benefit/ (expense) | (48) | (2,730) | 529 | (8,864) | ||||
Total other comprehensive income (loss) | (2,197) | $ 6,692 | $ (5,759) | 972 | $ (3,276) | $ 11,378 | (1,264) | 9,074 |
Defined benefit and other postretirement plans | ||||||||
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | (284) | (1,279) | 304 | (1,383) | ||||
Tax benefit/ (expense) | 71 | 317 | (76) | 343 | ||||
Total other comprehensive income (loss) | (213) | (962) | 228 | (1,040) | ||||
Net prior service credit (cost) | ||||||||
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | (31) | (53) | (94) | (158) | ||||
Tax benefit/ (expense) | 8 | 13 | 23 | 39 | ||||
Total other comprehensive income (loss) | (23) | (40) | (71) | (119) | ||||
Net gain (loss) | ||||||||
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | (253) | (1,226) | 398 | (1,225) | ||||
Tax benefit/ (expense) | 63 | 304 | (99) | 304 | ||||
Total other comprehensive income (loss) | (190) | (922) | 299 | (921) | ||||
Net gain (loss) from hedging activities | ||||||||
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | 1,247 | 12,188 | (1,998) | 36,827 | ||||
Tax benefit/ (expense) | (119) | (3,047) | 605 | (9,207) | ||||
Total other comprehensive income (loss) | 1,128 | 9,141 | (1,393) | 27,620 | ||||
Foreign currency translation | ||||||||
Other Comprehensive Income (Loss) [Line Items] | ||||||||
Pre-tax amount | (3,112) | (7,207) | (99) | (17,506) | ||||
Tax benefit/ (expense) | 0 | 0 | 0 | 0 | ||||
Total other comprehensive income (loss) | $ (3,112) | $ (7,207) | $ (99) | $ (17,506) |
Stockholders' Equity - Change b
Stockholders' Equity - Change by Component (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Beginning balance | $ 667,764 | $ 674,151 | $ 707,229 | $ 778,184 | $ 765,631 | $ 740,737 | $ 707,229 | $ 740,737 |
Other comprehensive income (loss) before reclassifications | 12,165 | 8,485 | ||||||
Amounts reclassified from accumulated other comprehensive income | (13,429) | 589 | ||||||
Total other comprehensive income (loss) | (2,197) | 6,692 | (5,759) | 972 | (3,276) | 11,378 | (1,264) | 9,074 |
Ending balance | 677,856 | 667,764 | 674,151 | 739,525 | 778,184 | 765,631 | 677,856 | 739,525 |
Total | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Beginning balance | 6,925 | 233 | 5,992 | 2,310 | 5,586 | (5,792) | 5,992 | (5,792) |
Total other comprehensive income (loss) | (2,197) | 6,692 | (5,759) | 972 | (3,276) | 11,378 | ||
Ending balance | 4,728 | $ 6,925 | 233 | 3,282 | $ 2,310 | 5,586 | 4,728 | 3,282 |
Defined benefit and other postretirement plans | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Beginning balance | (508) | 2,168 | (508) | 2,168 | ||||
Other comprehensive income (loss) before reclassifications | 207 | (1,157) | ||||||
Amounts reclassified from accumulated other comprehensive income | 21 | 117 | ||||||
Total other comprehensive income (loss) | (213) | (962) | 228 | (1,040) | ||||
Ending balance | (280) | 1,128 | (280) | 1,128 | ||||
Net gain (loss) from hedging activities | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Beginning balance | 24,672 | 290 | 24,672 | 290 | ||||
Other comprehensive income (loss) before reclassifications | 12,057 | 27,148 | ||||||
Amounts reclassified from accumulated other comprehensive income | (13,450) | 472 | ||||||
Total other comprehensive income (loss) | 1,128 | 9,141 | (1,393) | 27,620 | ||||
Ending balance | 23,279 | 27,910 | 23,279 | 27,910 | ||||
Foreign currency translation | ||||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||||
Beginning balance | $ (18,172) | $ (8,250) | (18,172) | (8,250) | ||||
Other comprehensive income (loss) before reclassifications | (99) | (17,506) | ||||||
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | ||||||
Total other comprehensive income (loss) | (3,112) | (7,207) | (99) | (17,506) | ||||
Ending balance | $ (18,271) | $ (25,756) | $ (18,271) | $ (25,756) |
Stockholders' Equity - Reclassi
Stockholders' Equity - Reclassifications out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Other (expense) income | $ (361) | $ (1,872) | $ (543) | $ (2,497) |
Total before tax | 24,465 | 30,291 | 58,850 | 70,428 |
Interest expense | 11,811 | 9,542 | 30,812 | 26,880 |
Tax (expense) benefit | (7,891) | (8,966) | (17,625) | (21,983) |
Amounts Reclassified from Accumulated Other Comprehensive Income | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Net of tax | 4,534 | (62) | 13,429 | (589) |
Defined benefit and other postretirement plans | Amounts Reclassified from Accumulated Other Comprehensive Income | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total before tax | (10) | (52) | (46) | (155) |
Tax (expense) benefit | 7 | 12 | 25 | 38 |
Net of tax | (3) | (40) | (21) | (117) |
Net prior service (credit) cost | Amounts Reclassified from Accumulated Other Comprehensive Income | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Other (expense) income | (31) | (53) | (94) | (158) |
Net (gain) loss | Amounts Reclassified from Accumulated Other Comprehensive Income | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Other (expense) income | 21 | 1 | 48 | 3 |
Net gain (loss) from hedging activities | Amounts Reclassified from Accumulated Other Comprehensive Income | Interest rate caps | ||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | ||||
Interest expense | 6,048 | (29) | 17,933 | (627) |
Tax (expense) benefit | (1,511) | 7 | (4,483) | 155 |
Net of tax | $ 4,537 | $ (22) | $ 13,450 | $ (472) |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||||
Apr. 27, 2022 | Aug. 31, 2022 | Sep. 30, 2023 | May 31, 2023 | Mar. 31, 2023 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Equity, Class of Treasury Stock [Line Items] | ||||||||
Excise Taxes Payable | $ 638 | $ 638 | $ 0 | |||||
Shares withheld for tax withholding obligation (in shares) | 315,635 | 32,058 | ||||||
Fair value of shares withheld for tax payments | 2,506 | $ 866 | $ 332 | $ 3,372 | $ 332 | |||
April 2022 Stock Repurchase Program | ||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Stock repurchase program, authorized amount | $ 450,000 | |||||||
Stock repurchase program, period (in years) | 4 years | |||||||
Remaining authorized repurchase amount | 234,592 | 234,592 | ||||||
Excise Taxes Payable | 638 | $ 638 | ||||||
April 2022 Stock Repurchase Program | Open Market | ||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Shares acquired (in shares) | 541,494 | 1,970,763 | ||||||
Average cost per share (in dollars per share) | $ 9.85 | $ 9.82 | ||||||
Repurchases of common shares value | $ 5,333 | $ 5,333 | $ 19,356 | |||||
April 2022 Stock Repurchase Program | Secondary Offering | ||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Shares acquired (in shares) | 6,500,000 | 7,000,000 | ||||||
Average cost per share (in dollars per share) | $ 8.36 | $ 10.48 | ||||||
Repurchases of common shares value | $ 54,316 | $ 73,374 |
Goodwill - Carrying Amounts (De
Goodwill - Carrying Amounts (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Beginning balance | $ 403,163 |
Foreign exchange impact | 205 |
Ending balance | 403,368 |
Ecoservices | |
Goodwill [Roll Forward] | |
Beginning balance | 326,589 |
Foreign exchange impact | 0 |
Ending balance | 326,589 |
Catalyst Technologies | |
Goodwill [Roll Forward] | |
Beginning balance | 76,574 |
Foreign exchange impact | 205 |
Ending balance | $ 76,779 |
Other Operating Expense, Net -
Other Operating Expense, Net - Summary (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Other Income and Expenses [Abstract] | ||||
Amortization expense | $ 2,645 | $ 2,632 | $ 7,924 | $ 7,931 |
Transaction and other related costs | 187 | 1,789 | 2,811 | 6,860 |
Restructuring, integration and business optimization costs | 310 | 2,338 | 2,438 | 8,011 |
Net loss on asset disposals | 1,020 | 468 | 3,326 | 1,174 |
Other, net | 148 | 446 | 789 | 1,125 |
Total other operating expense, net | $ 4,310 | $ 7,673 | $ 17,288 | $ 25,101 |
Inventories, Net - Classificati
Inventories, Net - Classification (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Inventory Disclosure [Abstract] | ||
Finished products and work in process | $ 44,406 | $ 39,909 |
Raw materials | 3,857 | 4,453 |
Inventories, net | 48,263 | 44,362 |
Valued at lower of cost or market: | ||
LIFO basis | 28,157 | 25,258 |
Valued at lower of cost and net realizable value: | ||
FIFO or average cost basis | $ 20,106 | $ 19,104 |
Investments in Affiliated Com_3
Investments in Affiliated Companies - Ownership Percentage (Details) | Sep. 30, 2023 |
Zeolyst International | |
Schedule of Equity Method Investments [Line Items] | |
Percent ownership | 50% |
Zeolyst C.V. | |
Schedule of Equity Method Investments [Line Items] | |
Percent ownership | 50% |
Investments in Affiliated Com_4
Investments in Affiliated Companies - Summarized Income Statement (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Schedule of Equity Method Investments [Line Items] | ||||||||
Gross profit | $ 53,184 | $ 67,669 | $ 150,648 | $ 175,263 | ||||
Operating income | 31,929 | 38,536 | 73,900 | 82,383 | ||||
Net income | 16,574 | $ 26,122 | $ (1,471) | 21,325 | $ 19,245 | $ 7,875 | 41,225 | 48,445 |
Equity Method Investment, Nonconsolidated Investee | ||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||
Sales | 81,115 | 67,043 | 236,200 | 218,389 | ||||
Gross profit | 22,205 | 17,794 | 66,776 | 70,546 | ||||
Operating income | 12,414 | 10,228 | 39,916 | 44,340 | ||||
Net income | $ 12,617 | $ 9,540 | $ 42,189 | $ 44,448 |
Investments in Affiliated Com_5
Investments in Affiliated Companies - Narrative (Details) - Business Combination - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Business Combination | |||||
Net purchase accounting fair value adjustments | $ 226,215 | $ 226,215 | $ 231,017 | ||
Amortization of investment in affiliate step-up | $ 1,601 | $ 1,601 | $ 4,802 | $ 4,802 |
Property, Plant and Equipment -
Property, Plant and Equipment - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment | ||
Property, plant and equipment, gross | $ 1,030,829 | $ 986,313 |
Less: accumulated depreciation | (450,020) | (401,424) |
Property, plant and equipment, net | 580,809 | 584,889 |
Land | ||
Property, Plant and Equipment | ||
Property, plant and equipment, gross | 96,686 | 96,659 |
Buildings and improvements | ||
Property, Plant and Equipment | ||
Property, plant and equipment, gross | 83,346 | 82,061 |
Machinery and equipment | ||
Property, Plant and Equipment | ||
Property, plant and equipment, gross | 802,823 | 751,145 |
Construction in progress | ||
Property, Plant and Equipment | ||
Property, plant and equipment, gross | $ 47,974 | $ 56,448 |
Property, Plant and Equipment_2
Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Property, Plant and Equipment [Abstract] | ||||
Depreciation | $ 17,773 | $ 16,103 | $ 51,920 | $ 48,256 |
Long-term Debt - Summary of Lon
Long-term Debt - Summary of Long-Term Debt (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Debt Instrument | ||
Total debt | $ 879,750 | $ 886,500 |
Original issue discount | (6,496) | (7,472) |
Deferred financing costs | (3,586) | (4,158) |
Total debt, net of original issue discount and deferred financing costs | 869,668 | 874,870 |
Less: current portion | (9,000) | (9,000) |
Total long-term debt, excluding current portion | 860,668 | 865,870 |
2021 Term Loan Facility | ||
Debt Instrument | ||
Total debt | 879,750 | 886,500 |
ABL Facility | ||
Debt Instrument | ||
Total debt | $ 0 | $ 0 |
Long-term Debt - Narrative (Det
Long-term Debt - Narrative (Details) $ in Thousands | 1 Months Ended | ||
Feb. 28, 2023 | Sep. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
2021 Term Loan Facility | |||
Debt Instrument | |||
Long-term debt, fair value | $ 875,351 | $ 870,986 | |
2021 Term Loan Facility | Secured Overnight Financing Rate | |||
Debt Instrument | |||
Credit spread adjustment | 0.10% | ||
Variable rate floor | 0.0050 | ||
Variable rate on spread | 2.75% | ||
First lien leverage ratio | 0.0250 | ||
Effective interest rate | 7.97% | ||
ABL Facility | Secured Overnight Financing Rate | |||
Debt Instrument | |||
Credit spread adjustment | 0.10% | ||
Effective interest rate | 8.75% | ||
ABL Facility | Secured Overnight Financing Rate | Minimum | |||
Debt Instrument | |||
Variable rate on spread | 1.25% | ||
ABL Facility | Secured Overnight Financing Rate | Maximum | |||
Debt Instrument | |||
Variable rate on spread | 1.75% | ||
ABL Facility | Base Rate | Minimum | |||
Debt Instrument | |||
Variable rate on spread | 0.25% | ||
ABL Facility | Base Rate | Maximum | |||
Debt Instrument | |||
Variable rate on spread | 0.75% |
Financial Instruments - Interes
Financial Instruments - Interest Rate Cap Agreements (Details) $ in Thousands | 9 Months Ended |
Sep. 30, 2023 USD ($) derivative_instrument_held | |
Derivative | |
Number of instruments | derivative_instrument_held | 4 |
Annuitized premium of instruments in effect | $ | $ 24,817 |
Cash flow hedging | |
Derivative | |
Number of instruments in effect | derivative_instrument_held | 3 |
Current notional amount of instruments in effect | $ | $ 650,000 |
Financial Instruments - Narrati
Financial Instruments - Narrative (Details) - Cash flow hedging $ in Thousands | 9 Months Ended |
Sep. 30, 2023 USD ($) derivative_instrument_held | |
Derivative | |
Number of instruments in effect | derivative_instrument_held | 3 |
Notional amount | $ 650,000 |
Derivative, cap interest rate | 1% |
Amount of derivative loss expected to be transferred from OCI | $ 9,963 |
January 2022 Interest Rate Cap expiring October 2024 | |
Derivative | |
Notional amount | 250,000 |
January 2022 Interest Rate Cap expiring October 2025 | |
Derivative | |
Notional amount | 250,000 |
November 2022 Interest Rate Cap - July 2023 to July 2024 | |
Derivative | |
Notional amount | 150,000 |
November 2022 Interest Rate Cap - August 2024 to July 2026 | |
Derivative | |
Notional amount | $ 175,000 |
Financial Instruments - Fair Va
Financial Instruments - Fair Values of Derivative Instruments Held (Details) - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
Derivative assets | ||
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] | Prepaid and other current assets | Prepaid and other current assets |
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other long-term assets | Other long-term assets |
Derivative asset, current | $ 16,374 | $ 18,510 |
Derivative liabilities | ||
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other long-term liabilities | Other long-term liabilities |
Derivatives designated as hedging instrument | Cash flow hedging | Interest rate caps | ||
Derivative assets | ||
Derivative asset, current | $ 16,374 | $ 18,510 |
Derivative asset, noncurrent | 15,804 | 15,864 |
Interest rate caps | 32,178 | 34,374 |
Derivative liabilities | ||
Derivative liability, noncurrent | 0 | 2,071 |
Derivative liability | $ 0 | $ 2,071 |
Financial Instruments - Effect
Financial Instruments - Effect of Derivative Instruments Designated as Hedges on Other Comprehensive Income (Details) - Interest rate caps - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Amount of gain (loss) recognized in OCI on derivatives | ||||
Amount of gain (loss) recognized in OCI on derivatives | $ 7,294 | $ 12,159 | $ 15,935 | $ 36,200 |
Interest (expense) income | ||||
Amount of gain (loss) reclassified from AOCI into income | ||||
Amount of gain (loss) reclassified from AOCI into income | $ 6,048 | $ (29) | $ 17,933 | $ (627) |
Financial Instruments - Cash Fl
Financial Instruments - Cash Flow Hedge Impact on Income Statement (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Derivative | ||||
Interest Expense | $ (11,811) | $ (9,542) | $ (30,812) | $ (26,880) |
Gain (loss) on cash flow hedging relationships | Amount of loss reclassified from AOCI into income | ||||
Derivative | ||||
Interest Expense | $ 6,048 | $ (29) | $ 17,933 | $ (627) |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate | 32.30% | 29.60% | 29.90% | 31.20% |
Benefit Plans - Components of N
Benefit Plans - Components of NPBC (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Defined Benefit Pension Plans | ||||
Defined Benefit Plan, Net Periodic Expense (Benefit) | ||||
Interest cost | $ 863 | $ 681 | $ 2,590 | $ 1,888 |
Expected return on plan assets | (826) | (380) | (2,479) | (2,599) |
Settlement loss | 22 | 38 | 50 | 38 |
Net periodic expense (benefit) | 59 | 339 | 161 | (673) |
Other Postretirement Benefits Plan | ||||
Defined Benefit Plan, Net Periodic Expense (Benefit) | ||||
Interest cost | 6 | 5 | 18 | 13 |
Amortization of prior service credit | (31) | (53) | (94) | (158) |
Amortization of net loss | (1) | 1 | (2) | 3 |
Net periodic expense (benefit) | $ (26) | $ (47) | $ (78) | $ (142) |
Reportable Segments - Summary F
Reportable Segments - Summary Financial Information by Reportable Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Segment Reporting | ||||
Sales | $ 173,326 | $ 232,533 | $ 518,310 | $ 637,419 |
Equity in net income from affiliated companies | 4,708 | 3,169 | 16,305 | 17,422 |
Ecoservices | ||||
Segment Reporting | ||||
Sales | 147,629 | 195,674 | 443,433 | 542,703 |
Catalyst Technologies | ||||
Segment Reporting | ||||
Sales | 25,697 | 36,859 | 74,877 | 94,716 |
Catalyst Technologies | Zeolyst Joint Venture | ||||
Segment Reporting | ||||
Sales | 36,958 | 27,773 | 103,721 | 92,656 |
Adjusted EBITDA from reportable segments | 9,640 | 8,704 | 31,270 | 34,306 |
Equity in net income from affiliated companies | 4,748 | 3,187 | 16,356 | 17,500 |
Amortization of investment in affiliate step-up | 1,601 | 1,601 | 4,802 | 4,802 |
Joint venture depreciation, amortization and interest | 3,291 | 3,917 | 10,112 | 12,004 |
Operating segments | ||||
Segment Reporting | ||||
Adjusted EBITDA from reportable segments | 71,034 | 83,382 | 206,316 | 231,111 |
Operating segments | Ecoservices | ||||
Segment Reporting | ||||
Sales | 147,629 | 195,674 | 443,433 | 542,703 |
Adjusted EBITDA from reportable segments | 54,674 | 64,110 | 151,598 | 173,435 |
Operating segments | Catalyst Technologies | ||||
Segment Reporting | ||||
Sales | 25,697 | 36,859 | 74,877 | 94,716 |
Adjusted EBITDA from reportable segments | $ 16,360 | $ 19,272 | $ 54,718 | $ 57,676 |
Reportable Segments - Reconcili
Reportable Segments - Reconciliation of Net Income to Segment Adjusted EBITDA (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Segment Reporting Information | ||||
Income before income taxes | $ 24,465 | $ 30,291 | $ 58,850 | $ 70,428 |
Interest expense, net | 11,811 | 9,542 | 30,812 | 26,880 |
Net loss on asset disposals | 1,020 | 468 | 3,326 | 1,174 |
Transaction and other related costs | 187 | 1,789 | 2,811 | 6,860 |
Equity-based compensation | 3,477 | 4,740 | 12,547 | 17,419 |
Restructuring, integration and business optimization expenses | 310 | 2,338 | 2,438 | 8,011 |
Segment reconciling items | ||||
Segment Reporting Information | ||||
Interest expense, net | 11,811 | 9,542 | 30,812 | 26,880 |
Depreciation and amortization | 21,290 | 19,599 | 62,456 | 58,803 |
Unallocated corporate expenses | 3,163 | 7,945 | 16,243 | 23,543 |
Joint venture depreciation, amortization and interest | 3,292 | 3,917 | 10,112 | 12,004 |
Amortization of investment in affiliate step-up | 1,601 | 1,601 | 4,802 | 4,802 |
Net loss on asset disposals | 1,020 | 468 | 3,326 | 1,174 |
Foreign exchange loss (gain) | 774 | 1,030 | (362) | 2,179 |
LIFO (benefit) expense | 0 | (436) | 2,510 | (4) |
Transaction and other related costs | 187 | 1,789 | 2,811 | 6,860 |
Equity-based compensation | 3,477 | 4,740 | 12,547 | 17,419 |
Restructuring, integration and business optimization expenses | 310 | 2,338 | 2,438 | 8,011 |
Other | (356) | 558 | (229) | (988) |
Operating segments | ||||
Segment Reporting Information | ||||
Adjusted EBITDA from reportable segments | $ 71,034 | $ 83,382 | $ 206,316 | $ 231,111 |
Stock-Based Compensation - Narr
Stock-Based Compensation - Narrative (Details) | Sep. 30, 2023 shares |
Share-Based Payment Arrangement [Abstract] | |
Number of shares available for grant (in shares) | 9,413,264 |
Stock-Based Compensation - Rest
Stock-Based Compensation - Restricted Stock Units and Performance Stock Units (Details) | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Restricted Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Granted (in shares) | 1,195,835 |
Granted, weighted average grant date fair value (in dollars per share) | $ / shares | $ 9.84 |
Restricted Stock Units | Board of Directors | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award requisite service period (in years) | 1 year |
Restricted Stock Units | Employee | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award requisite service period (in years) | 3 years |
Performance Stock Units | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Granted (in shares) | 721,537 |
Granted, weighted average grant date fair value (in dollars per share) | $ / shares | $ 12.28 |
Performance Stock Units | 2023 Grants | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Granted (in shares) | 721,537 |
Award requisite service period (in years) | 3 years |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | |
Expected dividend yield | 0% |
Risk-free interest rate | 3.80% |
Expected volatility | 48.82% |
Expected term (in years) | 2 years 11 months 15 days |
Performance Stock Units | 2023 Grants | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 0% |
Performance Stock Units | 2023 Grants | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 200% |
Performance Stock Units | 2020 Grants | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award requisite service period (in years) | 3 years |
Performance Stock Units | 2020 Grants | Company Performance Measure | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 53.30% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | |
Granted, percentage of target | 0.50 |
Performance Stock Units | 2020 Grants | Total Shareholder Return (TSR) | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 56% |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | |
Granted, percentage of target | 0.50 |
Performance Stock Units | 2020 Grants | Minimum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 0% |
Performance Stock Units | 2020 Grants | Maximum | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Award vesting percentage | 200% |
Restricted Stock | |
Share-based Compensation Arrangement by Share-based Payment Award | |
Granted (in shares) | 5,081 |
Granted, weighted average grant date fair value (in dollars per share) | $ / shares | $ 9.84 |
Stock-Based Compensation - Sche
Stock-Based Compensation - Schedule of RSU and PSU Activity (Details) | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Restricted Stock Units | |
Number of units | |
Nonvested, beginning balance (in shares) | shares | 2,464,718 |
Granted (in shares) | shares | 1,195,835 |
Vested (in shares) | shares | (1,436,301) |
Forfeited (in shares) | shares | (195,334) |
Nonvested, ending balance (in shares) | shares | 2,028,918 |
Weighted average grant date fair value (per share) | |
Nonvested, beginning balance (in dollars per share) | $ / shares | $ 11.73 |
Granted (in dollars per share) | $ / shares | 9.84 |
Vested (in dollars per share) | $ / shares | 11.84 |
Forfeited (in dollars per share) | $ / shares | 11.37 |
Nonvested, ending balance (in dollars per share) | $ / shares | $ 10.57 |
Performance Stock Units | |
Number of units | |
Nonvested, beginning balance (in shares) | shares | 639,532 |
Granted (in shares) | shares | 721,537 |
Vested (in shares) | shares | (200,204) |
Forfeited (in shares) | shares | (183,864) |
Nonvested, ending balance (in shares) | shares | 977,001 |
Weighted average grant date fair value (per share) | |
Nonvested, beginning balance (in dollars per share) | $ / shares | $ 16.32 |
Granted (in dollars per share) | $ / shares | 12.28 |
Vested (in dollars per share) | $ / shares | 20.48 |
Forfeited (in dollars per share) | $ / shares | 19.50 |
Nonvested, ending balance (in dollars per share) | $ / shares | $ 11.88 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 07, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Stock compensation expense | $ 3,477 | $ 4,740 | $ 12,547 | $ 17,419 | |
Stock-based compensation expense, tax benefit | 826 | $ 1,162 | $ 2,980 | $ 4,271 | |
Stock Options | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Forfeited, performance-based stock options (in shares) | 284,956 | ||||
Vested stock options, expired and unexercised (in shares) | 328,677 | ||||
Restricted Stock | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Forfeited, performance-based restricted shares (in shares) | 277,056 | ||||
Restricted Stock Units | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Forfeited, performance-based restricted shares (in shares) | 195,334 | ||||
Unrecognized stock-based compensation expense | 13,205 | $ 13,205 | |||
Unrecognized stock-based compensation expense, period for recognition | 2 years 7 days | ||||
Performance Stock Units (PSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Unrecognized stock-based compensation expense | $ 7,377 | $ 7,377 | |||
Unrecognized stock-based compensation expense, period for recognition | 2 years 3 months 21 days |
Earnings per Share - Reconcilia
Earnings per Share - Reconciliation from Basic to Diluted Weighted Average Shares Outstanding (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Earnings Per Share [Abstract] | ||||
Weighted average shares outstanding – Basic (in shares) | 116,446,085 | 132,622,105 | 119,042,161 | 136,115,598 |
Dilutive effect of unvested common shares and restricted stock units with service conditions, performance stock units considered probable of vesting and assumed stock option exercises and conversions (in shares) | 928,262 | 1,474,734 | 1,374,971 | 1,550,617 |
Weighted average shares outstanding – Diluted (in shares) | 117,374,347 | 134,096,839 | 120,417,132 | 137,666,215 |
Earnings per Share - Calculatio
Earnings per Share - Calculation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Numerator: | ||||||||
Net income | $ 16,574 | $ 26,122 | $ (1,471) | $ 21,325 | $ 19,245 | $ 7,875 | $ 41,225 | $ 48,445 |
Denominator: | ||||||||
Weighted average shares outstanding – Basic (in shares) | 116,446,085 | 132,622,105 | 119,042,161 | 136,115,598 | ||||
Weighted average shares outstanding – Diluted (in shares) | 117,374,347 | 134,096,839 | 120,417,132 | 137,666,215 | ||||
Net income per share: | ||||||||
Basic income per share (in dollars per share) | $ 0.14 | $ 0.16 | $ 0.35 | $ 0.36 | ||||
Diluted income per share (in dollars per share) | $ 0.14 | $ 0.16 | $ 0.34 | $ 0.35 |
Earnings per Share - Anti-dilut
Earnings per Share - Anti-dilutive Shares (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Restricted stock awards with performance only targets not achieved | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||||
Anti-dilutive stock options (in shares) | 0 | 505,439 | 65,966 | 574,048 |
Stock options with performance only targets not achieved | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||||
Anti-dilutive stock options (in shares) | 0 | 300,788 | 68,890 | 316,187 |
Anti-dilutive restricted stock units and performance stock units | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||||
Anti-dilutive stock options (in shares) | 0 | 487,322 | 0 | 19,306 |
Anti-dilutive stock options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ||||
Anti-dilutive stock options (in shares) | 454,461 | 751,539 | 556,114 | 788,509 |
Supplemental Cash Flow Inform_3
Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash paid during the period for: | ||
Income taxes, net of refunds | $ 19,019 | $ 24,367 |
Interest | 28,466 | 24,390 |
Non-cash investing activity: | ||
Capital expenditures acquired on account but unpaid as of the period end | 589 | 4,993 |
Non-cash financing activity: | ||
Accrued excise tax on share repurchases | 638 | 0 |
Right-of-use assets obtained in exchange for new lease liabilities (non-cash): | ||
Operating leases | $ 8,048 | $ 6,187 |